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ATCC  American Tissue Culture Collection 
aaRNA aminoallyl-modified RNA 
aaUTP  aminoally-UTP 
AmpR  Ampicillin resistance 
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et al.   and others 
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NCBI   National Center for Biotechnology Information  
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NLS   Nuclear Localization Sequence 
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Oligo  Oligonucleotide  
ON  Overnight 
pA  polyadenilation signal 
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PCR   Polymerase Chain Reaction  




pH  Negative decimal logarithm of the hydrogen ions (H+)  
PI3K  Phosphoinositide 3-kinase 
PLL  Poly-L-Lysin 
RLUs   Relative Luciferase Units 
RNA  ribonucleic acid 
RNase   Ribonuclease  
RT   Room Temperature  
SDS   Sodium Dodecyl Sulfate 
SHC  Src Homology 2 Domain Containing Transforming Protein 
SOC  Super Optimal Broth medium with Catabolite repression  
SV40   Simian Virus 40  
TAE   Tris-Acetate-EDTA  
Taq   Thermus aquaticus  
TATA  TATA-box  
TB   Terrific Broth  
TEV  Tobacco Etch Virus NIa protease 
TK   Thymidinkinase promoter (from herpes simplex virus) 
Tm  Melting temperature 
Tris  Tris(hydroxymethyl)aminomethane 
UTP  Uridine triphosphate 
UV   Ultraviolet  
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g   gram      G    guanine 
b  bases      T   thymine 
bp   base airs     C   cytosine 
°C   degrees Celsius    U  uracil 
h   hour      W   A or T   
kb   kilobase     S   G or C  
kD   kilo dalton     N   any base 
l  liter 
M   molar 
min   minute  
n   number 
OD   optical density  
rpm   rotation per minute  
sec  seconds 
U   units of enzymatic activity  
V  volume  




m   milli  (10-3)   
µ   micro (10-6)   
n   nano  (10-9)   
p   pico  (10-12)   




The ability to monitor multiple signaling events simultaneously in living cells 
is essential to better understand complex biological processes. So far, DNA-
microarray technologies provide global scale data mainly restricted to the level of 
gene expression. This information is not sufficient to understand the upstream 
regulatory mechanisms that lead to gene expression changes. Most proteomic 
technologies also provide large scale measurement but usually depend on in vitro 
synthesized peptides or require biochemical manipulations. High throughput 
technologies are required for functional characterization and monitoring of signaling 
components in living cells.  
Here, an experimental approach is presented termed EXTassay that enables 
quantitative and parallel measurements of various signaling events upstream of 
mRNA expression. EXTassay incorporates various cellular assays that are coupled to 
reporter gene expression. To achieve multiplexing, we have generated a complex and 
optimized library of short expressed oligonucleotide tags (EXTs). Each unique EXT 
can replace a classical reporter gene and serves as a unique identifier for tracking and 
quantification of a defined cellular assay. Multiple EXT-reporters expressed in the 
same cell or cell population can be isolated and analyzed by custom microarray 
hybridization. We have established protocols and optimized the microarray readout 
for reliable EXT quantification. We applied the EXTassay to analyze the neuregulin 1 
induced ErbB receptor tyrosine kinase signaling in PC-12 cells. We used 
transcriptionally coupled split-TEV protein complementation assays to monitor ErbB 
receptor dimerization and phosphorylation dependent interaction with downstream 
signaling proteins. In addition, we employed 30 different cis-regulatory elements to 
assess the downstream signaling. All assays were coupled to unique EXTs and 
analyzed by microarrays. By analyzing three different receptor complexes (ErbB2/2, 
2/3 and 2/4), we were able to measure receptor specific differential signaling effects 
and demonstrate that EXTassays can be applied for the quantitative profiling of 







To maintain homeostasis cells adapt continuously to changing environmental 
conditions. Genetic and environmental factors can lead to a progressive aberration of 
this adaptive behavior (Fishman and Porter 2005). One example for such a process is 
the development of cancer. According to the current state of research cancer cells lose 
progressively diverse mechanisms that inhibit uncontrolled proliferation. The 
interaction of these processes, however, has not been properly understood (Araujo, 
Liotta et al. 2007). Other examples comprise genetic complex and often chronic 
psychiatric disorders (Agid, Buzsaki et al. 2007). The complex genetic disorders as 
well as the simple monogenic (mendelian) disorders have in common that the 
dynamic equilibrium of physiologic processes in the cell changes at a certain time. 
Only an improved understanding of all cellular processes can lead to the development 
of new therapies and new pharmaceutical agents (Fishman and Porter 2005). The 
advent of modern genomic and proteomic technologies has dramatically changed the 
current concepts of molecular biology as exemplified by the paradigm shift in cellular 
signaling. Linear cascade models evolved towards highly interconnected signaling 
networks operating at multiple levels e.g. offering new perspective on drug discovery 
opportunities (Papin, Hunter et al. 2005; Kitano 2007; Hopkins 2008). Lessons 
learned from drug discovery show that focusing on one or several proteins that have 
been proven to play an important role in particular disease might not be sufficient to 
predictably modulate the behavior of the system (Kitano 2007). The findings of 
systems biology showed that the normal or pathologic behaviour of cells has to be 
understood in the context of the interaction of all cellular components (Friedman and 
Perrimon 2007; Perrimon, Friedman et al. 2007). 
Fast development of novel technologies gives rise to highly multiplexed experimental 
approaches that deal not only with gene expression changes but with a variety of 
cellular assays to gain an insight into signal transduction mechanisms and other 
cellular functions. Such assays hold a promise for more successful identification of 




High throughput technologies 
Collection of comprehensive data sets with standard techniques of biochemistry and 
cell biology is very tedious and cost intensive. Moreover large scale data sets 
collected so far are mostly based on in vitro analysis (Natarajan, Lin et al. 2006).  
Several high throughput methods can be used to analyze cellular functions (Chanda 
and Caldwell 2003). Developments in high throughput microscopy and image 
analysis have opened a way for large dataset collections using well established 
cellular assays based on fluorescent reporters. High-throughput microscopy has been 
successfully used to e.g. monitor the dynamics of the subcellular distribution of GFP-
fusion constructs (Starkuviene, Liebel et al. 2004), to quantify GFP-complementation 
based signaling sensors in living cells (MacDonald, Lamerdin et al. 2006) or to 
analyze transfected cell arrays (Bailey, Wu et al. 2002). Flow cytometry is another 
technique often used for high throughput quantification of fluorescent reporters or 
FRET assays (Gertz and Cohen 2009). Fixation protocols for quantitative 
immunocytochemical analyses have been combined with color-barcoding schemes to 
achieve multiplexing (Krutzik and Nolan 2006). Multiplexed RNAi screening 
strategies are being used to determine loss of function phenotypes on the large scale 
(Schlabach, Luo et al. 2008). Protein-interaction measurements with two-hybrid 
assays have been multiplexed using yeast-arrays (Suter, Fetchko et al. 2007; Suter, 
Kittanakom et al. 2008).  
Protein arrays are commonly used in high throughput proteomics to collect large 
datasets on protein-protein interaction. This technique is a pure in vitro approach that 
uses antibodies or spotted peptides obtained by vitro translation. Such approach might 
not be informative for functional assessments of full length transmembrane proteins 
or transiently modified signaling proteins. Identification of protein composition by 
mass spectrometry is another powerful proteomics technology that works in vitro with 
extracted proteins and is not capable to provide dynamic information about the 
functional state of full length proteins in their native cellular environment. 
So far, most techniques are restricted to a particular biochemical reaction or class of 
molecules and thus can only provide an isolated picture of the molecularly very 





The entirety of transcripts, i.e. those parts of the genome that are used for the 
synthesis of mRNA, is known as the “transcriptome”. It is far more dynamic and 
complex then thought a few years ago. The most advanced technology for the high 
throughput screening of the transcriptome at the moment is the “microarray” 
technology (Chanda and Caldwell 2003). Microarrays rely on the specific 
hybridization of nucleic acids in solution (targets) with complementary nucleic acids 
bound to a solid surface (probes).  A reliable analysis of almost the complete 
transcriptome is possible due to the sequence-specific recognition between unique 
probes and corresponding targets. The first microarrays were applied for gene 
expression analysis in 1995 with only 45 genes (Schena, Shalon et al. 1995). Since 
then, the microarray technique has made a tremendous progress and became a widely 
used and very powerful technology that made invaluable contributions for functional 
genomics. Three different approaches to microarray manufacturing were developed 
simultaneously: inkjet printing (by Edwin Southern) and photolithography (by 
Stephen Fodor) are two different approaches for the de novo synthesis of 
oligonucleotides on the glass surface (Fodor, Rava et al. 1993) and an alternative 
technique developed by Patrick Braun based on spotting readily available PCR 
products with the help of tiny pins. First whole genome microarrays were performed 
to analyze gene expression in yeast using the spotting technology (DeRisi, Iyer et al. 
1997). Recently, a modification of photoactivated in situ oligo synthesis technology 
was introduced using electronically manipulated micromirrors of the digital light 
processor device instead of photolithographic masks (Nuwaysir, Huang et al. 2002). 
All platforms have proven to be reliable and useful for gene expression studies and 
many other applications. However preparation of self-spotted microarrays is time 
consuming and does not guarantee reproducible quality from array to array. 
Microarray based transcriptomics continues to generate new data unraveling novel 
phenomena in cellular function and disease mechanisms. Microarray technology has 
enabled not only genome scale transcriptomic research but also other kinds of high 
throughput assays such as chromatin immunoprecipitation, single nucleotide 
polymorphism, profiling of small non coding RNA expression and other (Zhao, Yin et 
al. 2007). Alternatively, high throughput sequencing techniques may complement 
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microarray approaches for globally scaled analyses of the genome and transcriptome 
in the near future (Shendure 2008; Shendure, Porreca et al. 2008). 
Barcode arrays: novel applications of the established 
technology 
Microarray technologies are used for sequence specific detection and quantification of 
DNA and RNA samples not only from natural biological samples but also from 
synthetic DNA libraries. Such DNA sequences are used as unique identifiers 
(barcodes or tags) linked to other molecules such as siRNAs or targeting vectors to 
generate tagged null alleles via recombination in yeast. Multiple DNA barcodes are 
quantified by hybridization to a diagnostic microarray or by high throughput 
sequencing (Mannocci, Zhang et al. 2008). DNA-based molecular barcodes analyzed 
by microarray hybridization have proven to be useful in several applications. A 
library of yeast deletion mutants was constructed covering 96% of all annotated 
Saccharomyces cerevisiae open reading frames where each deleted gene was replaced 
by a barcode DNA sequences for tracking of individual deletion strains. This enabled  
quantitative survival assay for all the mutants grown in one culture by measurement 
of the relative abundance of the unique DNA barcodes (Giaever, Chu et al. 2002). The 
technique was also applied to characterize drug sensitivities of tagged heterozygote 
strains and to study the interaction of various drugs with certain genetic backgrounds 
(Giaever, Shoemaker et al. 1999). Such approaches are helpful for the identification 
of drug targets or mechanisms of their action (Lum, Armour et al. 2004). In another 
“barcode” application,DNA sequences were used in combination with specific 
shRNAs targeting up to 20 000 different genes in human mammary epithelial cell 
lines MCF-10A and MDF-MB435. The barcode sequences were used in a fashion 
similar to the yeast approach to quantify the impact of specific shRNAs on cell 
survival (Silva, Marran et al. 2008). Unique DNA sequences can also serve for 
measurement of multiple cellular assays within one cell. The authors of a recent 
review suggested using unique oligonucleotides as specific reporter genes for the 
measurement of multiple transcription factor activities and for parallel assessment of 
transcription factor DNA binding in vitro and for identification of transcription factor 
complexes with pull down assays (Li, Jiang et al. 2006) 
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Reporter gene assays 
A reporter gene typically encodes a protein or enzyme which is induced by a cellular 
process of interest and which can be easily detected and quantified. A reporter gene 
consists of a regulatory DNA sequence (a cis-regulatory element or a promoter) 
coupled, in the classical version, to an open reading frame of a reporter protein. The 
most widely used reporter proteins are: (i) fluorescent proteins, (ii) enzymes, (iii) 
selection markers such as antibiotic resistance proteins, proteins conferring sensitivity 
to a factor supplied with medium or metabolic enzymes that rescue corresponding 
biosynthetic pathway in a deficient strain. The last category is usually not used for 
quantitative analysis but rather for high throughput applications where the selection of 
only positive hits is desired.  
In contrary, a variety of reporter enzymes are being used for highly sensitive 
quantitative analysis. Depending on the type of the substrate used, the enzyme activity 
is measured by chemiluminescence, fluorescence or light absorption. The enzymatic 
nature of the readout results in signal amplification as each molecule of the enzyme 
converts multiple substrate molecules at very high speed leading to high signal 
intensities. Therefore, enzymatic assays can pick up subtle signals and can be 
performed with low cell numbers. Among the most often used reporter enzymes are β-
Galactosidase, β-Lactamase, placental alkaline phosphatase and different Luciferase 
enzymes.  
Reporter gene assays are widely used and have become a golden standard for 
transcription factor activity measurement. They have been successfully used for drug 
discovery purposes in high throughput screening of chemical libraries. For example 
such assays have proven to be useful in the search for G-protein coupled receptor 
(GPCR) agonists, the procedure called receptor deorphanization (Hill, Baker et al. 
2001; Johnston 2002). A prototype assay is carried out using a cell line stably 
transfected with a reporter construct carrying a cis-regulatory element that is 
indicative of the receptor activation. Ligand efficacy is assessed by the reporter gene 
expression level. For more informative assays, several different reporter constructs 
were used coupled to different reporters (Kotarsky, Nilsson et al. 2003). For example 
the c-fos promoter was often used in reporter constructs since it carries several 
different cis-elements. These simple assays are used to get a first indication of a 
possible interesting hit. By using multiple and diverse reporters much more 
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information could be learned about the drug responses elicited in living cells. Diverse 
assay formats can be coupled to reporter gene expression that covers a considerable 
portion of all cellular events involved in signal transduction. For example detailed 
analysis of the transcriptional regulation can be done by measurement of promoter 
activities regulated by multiple transcription factors compared to activities of isolated 
cis-regulatory elements that are bound by specific transcription factors. For the 
proteins that regulate transcription but don’t act as transcription factors themselves 
protein/DNA binding can be assessed by one hybrid assay (Deplancke, Dupuy et al. 
2004). Protein-protein interactions in the nucleus are measured by two hybrid systems 
(Luo, Batalao et al. 1997). Regulated protein-protein interactions at the plasma 
membrane and in the cytosol constitute the main body of signal transduction networks 
and can be measured by a variety of protein complementation assays coupled to a 
transcriptional readout (Stagljar, Korostensky et al. 1998).  
Reporter gene assays are sensitive and flexible tools that allow measurement of a 
wide variety of different cellular events by selecting appropriate regulatory DNA 
sequences and assay designs.  
Multiplexed reporter gene assays 
Since reporter gene assays rely on a transcriptional readout, they enable the transition 
towards multiplexed assay formats by performing the analysis at the level of mRNA 
expression. In contrast to protein reporters, nucleic acid-based reporters can be 
reliably amplified up to high numbers. They can be also easily quantified in highly 
parallel manner by microarray hybridization or high throughput sequencing. One such 
multiplexed reporter system for quantification by using unique expressed 
oligonucleotide reporters was already mentioned above in the context of barcode 
arrays. The quantification was performed by microarray hybridization based on 
unique sequence of each reporter (Li, Jiang et al. 2006).   
An alternative version of multiplexed reporter gene assay was developed by using 
essentially the same sequence with a restriction site placed at different positions along 
the oligonucleotide. After endonuclease digestion the identity of the reporters was 
determined by the size of the resulting fragments. The abundance of each reporter was 
revealed by the size of the corresponding peak obtained by the capillary 
electrophoresis (Romanov, Medvedev et al. 2008). The approach was applied for 
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simultaneous analysis of 50 different cis-regulatory elements. Such a reporter system 
can easily be applied and is homogenous with respect to the performance of the 
individual reporters, however, the number of assays is limited to several hundreds and 
can not be scaled up to perform comprehensive analysis at the genome wide level. 
Reporter gene assays are very useful for further development of multiplexed 
approaches to elucidate cellular signaling because they provide large scale 
measurement options and allow coupling of various types of cellular assays to the 
same readout. 
Split-TEV assay 
Split-TEV is a protein complementation assay that is based on the reconstitution of 
tobacco etch virus NIa protease (TEV-protease) activity when two proteins of interest 
are found in close proximity for example during protein-protein interaction (Wehr, 
Laage et al. 2006). The TEV protease has high substrate specificity for a defined 
peptide motif (TEV-site) that is not found in mammalian proteins (Phan, Zdanov et al. 
2002). In order to enable a protein-protein interaction assay, the TEV protease is split 
into two fragments: a N-terminal (N-TEV) and a C-terminal (C-TEV) part in a way 
that the catalytic residues of the active site are shared between the fragments and thus 
neither of the fragments alone can exhibit proteolytic activity. Fusion constructs are 
generated to link each of the putative interaction partners to one of the TEV-protease 
fragments in a single polypeptide chain. Therefore, when the proteins of interest 
interact, the TEV fragments are bought into close proximity and can fold together to 
form a functional protease. Protease reconstitution is monitored by the cleavage of a 
specific substrate peptide to trigger the release of a transcription factor that 
translocates to the nucleus and activates the transcription of a corresponding reporter 
gene (Figure 1) (Wehr, Laage et al. 2006). In the case when transmembrane proteins 
are studied, no additional anchoring domain is required since the TEV-site and the 
transcription factor can be attached directly to one of the interaction partners via N-
terminal TEV fragment and hence kept at the plasma membrane. 
Compared to commonly used two-hybrid systems that rely on transcription factor 
reconstitution, the Split-TEV approach involves more steps from the actual interaction 
to the readout. However this is a trade off for one of the main advantages of the 
system which is high contextual specificity. Namely, protein-protein interactions can 
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be monitored at their native cellular localization and their function assessed at their 
native environment.  
 
 
Figure 1. The principle of the split-TEV assay. Split-TEV is a proximity based protease 
reconstitution assay for the measurement of protein-protein interactions with high contextual 
specificity. Two proteins of interest (A and B) are expressed as fusion constructs with the N- and the C-
terminal fragments of the tobacco etch virus protease (TEV). Upon interaction between the two 
proteins the inactive protease fragments are brought into close proximity and the protease activity is 
restored. This event is detected by the cleavage of a special proteolysis reporter protein that contains a 
transcription factor (TF) linked by the specific TEV protease cleavage site (tevS) to an anchor domain 
that ensures the cytosolic retention of the protein. Activation of the TEV protease leads to the release of 
the transcription factor that can then translocate to the nucleus and activate the transcription of an 
appropriate reporter gene.  
 
Dimerization of full length receptor tyrosine kinases were measured in response to 
ligand binding and phosphorylation dependent interaction of cytosolic proteins Bad 
and 14-3-3 was analyzed in the context of signal transduction (Wehr, Reinecke et al. 
2008). The ability to measure various types of interactions makes Split-TEV a well 
suited approach for studying signal transduction. Compared to other approaches that 
possess overt contextual specificity, Split-TEV does not rely on cell endogenous 
factors. The possibility of a transcriptional readout opens a way for multiplexed 
measurement of Split-TEV assays. A similar proximity based assay was developed 
using full length TEV protease. The TEV substrate is exposed to the protease that is 
recruited through protein-protein interaction leading to the transcription factor release 
(Barnea, Strapps et al. 2008). 
Other protein complementation assays 
Among other well known protein complementation assays coupled to a transcriptional 
readout are split-ubiquitin, split-intein and mammalian protein-protein interaction trap 
assay (MAPPIT). The split-ubiquitin approach relies on endogenous proteasome 
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activity to release the transcription factor after ubiquitin reconstitution upon protein-
protein interaction (Stagljar, Korostensky et al. 1998). The split intein system uses the 
mechanism of protein splicing intrinsic to the intein proteins to generate free a 
transcription factor upon intein reconstitution (Kanno, Ozawa et al. 2006). The 
MAPPIT assay is using a STAT recruitment deficient cytokine receptor that does not 
carry tyrosine residues fused to a protein of interest. Another protein of interest is 
fused to a functional phosphotyrosine domain that upon interaction rescues the 
signaling resulting in STAT transcription factor activation. (Eyckerman, Lemmens et 
al. 2002). This system is using bulky fusion proteins and depends to a large extent on 
endogenous signaling machinery and an endogenous transcription factor. Many more 
protein complementation assays (PCA) are available that, however, do not involve 
transcriptional readout and rely on reconstitution of a fluorescent protein (GFP 
variants) or an enzyme (e.g. Dihydrofolate reductase, β-Galactosidase, firefly or 
renilla Luciferase) reviewed in (Michnick 2003). 
ErbB signaling pathway 
Receptor tyrosine kinases are a class of cell surface receptors that utilize their intrinsic 
tyrosine kinase activity to transduce extracellular signals across the plasma 
membrane. A prototypic family of receptor tyrosine kinases is represented by the four 
closely related ErbB proteins ErbB1, ErbB2, ErbB3 and ErbB4 (alternatively named 
HER1, 2, 3 and 4 in humans). ErbB1 is also known as epidermal growth factor 
receptor (EGFR). The pathway that is initiated by the ErbB-receptor family is among 
the most extensive studied signaling networks and has been implicated in cancer, 
development and psychiatric diseases (Citri and Yarden 2006; Mei and Xiong 2008). 
Due to their role in breast, lung and colorectal cancer ErbB proteins have become 
major targets for anticancer drug development (Hynes and Lane 2005). Under normal  
physiological conditions, ErbB receptors regulate cell proliferation, differentiation 
and apoptosis  and play important roles in development (Holbro and Hynes 2004). 
ErbB receptors bind numerous growth factor ligands among which is the family of the 
neuregulin proteins that are encoded by 4 different genes (Nrg1-4). The best 




In the inactive state, extracellular 
domains II and IV of ErbBs interact and 
mask the dimerization arm in the domain 
II thereby keeping the ligand binding 
domains I and III open. Upon ligand 
binding, the domains II and IV are 
separated and the dimerization arm is 
exposed triggering back-to back 
dimerization of the activated receptors. 
In the case of the ligand binding 
deficient ErbB2 protein, the 
Figure 2 Domain structure and dimerization mechanism of the ErbB receptors. 
(adapted from Citri & Yarden, 2006). 
 
The family consists of 31 protein isoforms produced by alternative promoter usage 
and alternative splicing. Some of the neuregulin isoforms are transmembrane proteins 
involved in cell contact signaling and others are shaded and function as paracrine 
ligands but all of them share a conserved EGF domain that is required for signaling 
(Mei and Xiong 2008). All of the ErbB family members are single-transmembrane 
proteins that carry four domains in their extracellular region. Domains I and III 
contain cysteine rich clusters important for binding of peptide ligands. Domains II and 
IV are important for dimerization mechanism. Upon ligand binding, a dimerization 
arm is extended that enables homo and heterodimerization between the members of 
the family. In the case of ErbB2, the ligand binding domains I and III interact with 
each other leaving no place for the ligand, rendering the receptor deficient in ligand 
binding and permanently dimerization competent (Figure 2) (Garrett, McKern et al. 
2003). On the intracellular side, the ligand binding triggers activation of the tyrosine 
kinase domain that leads to auto- and cross-phosphorylation of the intracellular 
domains of both partners. The pattern of phosphorylated tyrosine residues is thought 
to determine downstream signaling pathways by recruitment of about 10 different 
signaling proteins containing either SH3 or PTB phosphotyrosine binding domains. 
The repertoire of binding partners for each ErbB-family member was characterized 
using protein arrays as well as pulldown experiments with peptides flanking all 





Figure 3. An overview of the Neuregulin/ErbB signaling. (adapted from Mei & Xiong, 2008). 
Transmembrane receptor tyrosine kinases of the ErbB family can form homo- and heterodimers upon 
binding of the neuregulin (Nrg). Ligand binding to ErbB3 and ErbB4 receptors initiate various 
downstream signaling cascades by recruitment of phosphotyrosine binding proteins such as Grb2, 
SHC, PI3K, etc. leading finally to activation of certain transcription factors and changes in gene 
expression. Two members of the ErbB family ErbB2 and ErbB3 are nonautonomous since ErbB2 can 
not bind ligands and ErbB3 caries an inactive tyrosine kinase domain. However, these two proteins 
form the most signaling potent heterodimer (Alimandi, Romano et al. 1995). This is probably due to 
the fact that ErbB2 is a strong dimerization partner and positive regulator for all ErbB proteins. The 
ErbB3 C-terminal domain exhibits enhanced activity in recruitment and activation of the downstream 
signaling proteins when phosphorylated by ErbB2. Only those receptor combinations are shown that 
are involved in Nrg signaling. ErbB2 and epidermal growth factor receptor (EGFR) do not bind Nrg 
which is designated by the black crosses. 
 
All of the ErbB receptors interact with SHC (Src homology 2 containing) and Grb2 
(growth factor receptor bound-2) proteins that are responsible for activation of MAP 
kinase pathway via SOS and Ras small GTPase (Figure 3). Another prominent 
effector protein is the p85 subunit of the PI3K (phosphatidyl inositol 3 kinase) that is 
recruited to six phosphotyrosine sites at the ErbB3 receptor and one site at the ErbB4. 
Apart from that, other important downstream effectors of the ErbB signaling are: 
signal transducer and activator of transcription proteins (STATs), SRC tyrosine 
kinase, phospholipase C gamma (PLCγ), mammalian target of rapamycin (mTOR) 
and protein kinase C (Olayioye 2001). 
It is important to point out that out of four members of the ErbB family only two 
(ErbB1 and ErbB4) can operate independently as homodimers because ErbB2 is 
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deficient in ligand binding and ErbB3 deficient in tyrosine kinase activity. However, 
both of them are fully functional as parts of heterodimers with other ErbB receptors 
(Figure 3). Moreover heterodimers comprised of ErbB2 and ErbB3 exhibit high 
signaling activity which is conferred by the strong signaling potency of the ErbB3 C-
terminal tail (Wallasch, Weiss et al. 1995; Waterman, Alroy et al. 1999). Furthermore, 
ErbB3 is thought to undergo an internalization pathway leading to its recycling back 
to the plasma membrane and not to the degradation as for the other ErbB proteins 
which may further contribute to the enhanced signaling (Waterman, Sabanai et al. 
1998). On the other hand ErbB2 has been shown to act as a preferred 
heterodimerization partner and a positive regulator for all the other ErbB receptors 
(Graus-Porta, Beerli et al. 1997). Despite its inability to bind ligands, overexpression 
of ErbB2 can elicit signaling leading to transformation of cell lines in culture and 
contributing to many human malignancies in particular breast cancer (Di Fiore, Pierce 
et al. 1987; Olayioye 2001). With multiple ligands and receptor combinations the 
ErbB-Nrg signaling pathway is a large and interconnected network that obviously 
needs to be analyzed at the systems level. Since many years, efforts are directed 
towards computer modeling of the ErbB signaling, however, there is still a significant 
lack of quantitative dynamic data that would characterize various aspects of signal 
transduction (Kholodenko, Demin et al. 1999; Schoeberl, Eichler-Jonsson et al. 2002). 
Therefore, high throughput technologies are required to generate such data for 


















Aim of the study  
Here, we present a novel integrated and scalable reporter system - which we termed 
EXTassay - to simultaneously monitor cellular signaling at multiple levels within 
living cells and under identical experimental conditions. The system can 
accommodate versatile reporter gene formats. In a proof of principle experiment, we 
combine split-TEV and cis-regulatory element analysis to simultaneously monitor 
ErbB receptor activation at the plasma membrane and downstream signaling at the 
level of transcription factors. Using different split-TEV assays, we quantitatively 
measure neuregulin1 (Nrg1) regulated ErbB receptor dimerization and 
phophorylation-dependent recruitment of first order signaling mediators (Wehr et al 
2006, 2008). In parallel, we measured the activity of more than twenty different cis-
regulatory elements to monitor the activity of different transcription factors to 



















Laboratory supplies and equipment. 
 
Equipment 
Picodrop Spectrophotometer    Picodrop Limited 
Agilent 2100 Bioanalyser     Agilent Biotechnologies  
7500 Fast Real-time PCR System    Applied Biosystems 
Microplate reader Mitras LB940    Berthold Technologies 
NimbleGen 4-bay Hybridization System   Roche NimbleGen 
QPix Colony Picking Robot    Genetix 
Microarray Scanner G2565AA    Agilent Biotechnologies 
Hybridization oven G2545A    Agilent Biotechnologies 
GenePix 4200A microarray scanner    Axon Instruments 
Biophotometer       Eppendorf  
Heraeus Biofuge Fresco     DJB Labcare 
Sorvall RC-5B Plus Ultracentrifuge    Thermo Scientific  
Centrifuge 5810R     Eppendorf 
Concentrator 5301     Eppendorf 
Thermocycler T3     Biometra 
Thermocycler TGradient    Biometra 
Hera Cell 150 Cell Culture Incubator   Thermo Scientific   
Hera Safe KS 12 Safe Workbench   Thermo Scientific 
Schaking Incubator Multitron  2   Infors HT 
Electrophoresis power supply     Pharmacia LKB 
UV Gel Documentation System    iNTAS 
Thermomixer comfort     Eppendorf  
Arium 611 Water Purification System    Sartorius 
Leica DM IRBE inverted microscope   Leica 
Ultra-Low Temperature Freezer U725   New Brunswick Scientific 
“GenePulser” electroporation device   BioRad 
 
Software 
Windows XP Professional    Microsoft 
Microsoft Office      Microsoft  
Acrobat Reader 7.0     Adobe 
Endnote X2       Thomson Research Soft 
Illustrator CS3      Adobe 
Lasergene 7.0.0      DNA Star Inc. 
Vector NTI Advance 10     Invitrogen 
GenePix Pro 6.1     Axon 
Feature extraction software     Agilent 
MicroWin 2000      Berthold Technologies  
R (statistical computing environment)   Open source 
 
Plastic ware 
General laboratory materials from Eppendorf, Falcon, Gilson and ABgene were used for 
molecular biology applications. For cell culture applications plastic wear from Falcon and 





Kits:   
QIAprep Spin Miniprep Kit     Qiagen 
QIAquick Gel Extraction Kit     Qiagen 
QIAfilter Midi und Maxi Kit     Qiagen  
NucleoSpin Plasmid Quick Pure    Macherey-Nagel 
NucleoBond PC100     Macherey-Nagel 
NucleoSpin Extract II     Macherey-Nage 
ChargeSwitch PCR Clean-Up Kit    Invitrogen 
T7 Megascript Kit     Ambion  
T3 Megascript Kit     Ambion 
NimbleGen Wash Buffer kit    Roche NimbleGen 
NimbleGen Sample Tracking Control Kit  Roche NimbleGen 
NimbleGen Hybridization Kit    Roche NimbleGen 
Pathway profiling Luciferase system 1   Clontech 
Pathway profiling Luciferase system 4   Clontech 
PCR Core Kit Plus     Roche 
Transcriptor High fidelity cDNA Synthesis Kit Roche  
RNeasy Mini Kit      Qiagen 
RNase-Free DNase Set     Qiagen 






General chemicals from Sigma-Aldrich or MERK were used unless stated otherwise. 
Agarose      Applichem 
Agar       BD 
Yeast extract       BD 
Bacto-Pepton       BD 
Trypton      BD 
GeneRuler 1 kb DNA ladder    Fermentas 
GeneRuler 100 bp DNA ladder     Fermentas 
6x DNA Loading Dye     Fermentas 
Power SYBR Green PCR Master Mix   Applied Biosystems 
Trizol reagent      Invitrogen 
5-(3-aminoallyl)-UTP     Ambion 
Hydroxylamine (4M)     Ambion 
Coupling buffer      Ambion 
Cy5 Mono-Reactive Dye Pack    GE Healthcare 
Cy3 Mono-Reactive Dye Pack    GE Healthcare 
Acetonitryl      J.T.Baker 
Fomamide      Sigma-Aldrich 
SSPE buffer (20x)     AppliChem 
Salmon Sperm DNA     Sigma-Aldrich 
Yeast tRNA      Sigma-Aldrich 
Blocking agent       Agilent Technologies   
HI-RPM microarray hybridization buffer  Agilent Technologies  







Cell culture media and reagents 
Dulbecco’s Modified Eagle Medium   Lonza   
OptiMEM reduced serum medium   Gibco 
McCoy’s 5A medium      Gibco 
Fetal Bovine Serum     Gibco 
Horse Serum      Gibco 
GlutaMax,       Gibco 
Penicillin/Streptomycin     Lonza 
Trypsin       Gibco 
Poly-L-Lysine      Sigma-Aldrich 
DMSO       Sigma-Aldrich 
Laminin      Sigma-Aldrich    
Lipofectamine 2000 Transfection Reagent  Invitrogen 
NGF       Peprotech 
Nrg1b        from Dr. T.Fischer 
dbcAMP      BioLog, Bremen 
Doxycyclin      Alexis Biochemicals 
Rapamycin      Alexis Biochemicals 
 
Enzymes 
Restriction enzymes      New England Biolabs  
REDTaq DNA polymerase    Sigma-Aldrich 
HotStarTaq DNA polymerase    Qiagen 
Taq polymerase      Roche 
Pfu Ultra DNA polymerase    Stratagene 
Easy-A HiFi PCR cloning enzyme   Stratagene 
T4 DNA ligase      Promega  
RQ1 DNase       Promega 
BP clonase II      Invitrogen 
LR clonase II Plus     Invitrogen 
LR conase      Invitrogen 
Superscript III Rverese Transcriplase   Invitrogen  
 
Microarrays 
Agilent 8x15K      Agilent Biotechnologies 
NimbleGen 4x72K     Roche NimbleGen 
CodeLink Activated Slides    Amerscham Biosciences 
Molecular biology solutions 
 
TAE 50x  
Tris-Acetate, pH 8.0     2 M 
EDTA       50 mM 
Glacial acetic acid     57,1 ml 
adjust the volume to 1 L  with H2O 
 
TE (Tris-EDTA) 
Tris-Cl       10 mM  
EDTA       1 mM  
adjust the pH to 7,4 
 
PEG solution 
PEG 8000      30% 





EtBr 1% in H2O     10 mg/ml    
Final concetration in a gel     1 µg/ml 
 
DNA loading buffer 
Bromphenolblue      0,25% 
Xylencyanol       0,25% 
Ficoll (Typ 400)      15% 
 
dNTP mix 50x  
(dATP, dCTP, dGTP, dTTP)    10 mM   (2,5 mM each) 
Final concentration in the PCR     200 µM (50 µM each) 
  
Primers 
Delivery concentration     50 pmol/µl 
Final concentration in the PCR reaction    0,2 µM  (5-10 pmol/reaction) 
 
LB-medium (Luria and Bertani medium) 
Yeast extract       0,5% (w/v)   
Bacto-Pepton pH7,5      1%  (w/v) 
NaCl        1%  (w/v) 
 
TB-medium (Terrific broth) 
Trypton       12 g 
Yeast extract       24 g 
Glycerin       4 ml 
H2O        900 ml 
Autoclave and cool down to 60°C  
add 20 ml of autoclaved 50x phosphate buffer: 
KH2PO4       0,17 M 
K2 HPO4       0,72 M 
 
Bacterial stock freezing medium 
Glycerol      65% (v/v)   
MgSO4       0,1 M   
Tris-Cl,  pH8      25 mM   
The solution has to be autoclaved 
 
SOC-Medium  
Bacto-Pepton       2%  (w/v)  
Yeast Extract      0,5%  (w/v)  
Glucose       20 mM  
NaCl        10 mM  
KCl        2,5 mM  
MgSO4       10 mM  
 
 
Antibiotics          f. c. in LB medium or agar plates 
Kanamycin      50 µg/ml 
Ampicillin       100 µg/ml 
Carbenicillin       100µg/ml 







Yeast extract       0,5% (w/v)   
Bacto-Pepton pH7,5      1%  (w/v) 
NaCl        1%  (w/v) 
Agar       1,5% (w/v) 
Autoclave, cool down to 55°C in a water bath, add antibiotics and pore the plates 
For blue-white selection include 
X-Gal  (5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside) 35 μg/ml  
IPTG   (Isopropyl-β-D-thiogalactopyranosid)   15 μg/ml  
 
Microarray related buffers and solutions 
 
MES 12x 
MES hydrate      64,61 g   
MES Sodium salt     139,3 g   
(1,22 M MES, 0,89 M Na+)  pH 6,5-7,5 
 
2 x Affymetrix Hybridization Buffer 
MES       10 mM 
NaCl       1M 
EDTA       20 mM 
Tween-20      0,01% 
 
Coupling buffer for the aaRNA labeling 
Na2CO3, pH 9,0      0,3 mM 
 
Coupling Neutralization Solution 
Hydroxylamine (Ambion)    4M  
 
Modified 2xHybridization Buffer (for Agilent microarrays) 
Salmon sperm DNA (10mg/ml)    1 mg/ml 
Yeats tRNA (4mg/ml)     0,4 mg/ml 
SSC (20x)      6x 
SDS (5%)      0,6% 
 
SSPE 20x          
NaCl       3,0 M   
NaH2PO4      200 mM  
EDTA       20 mM   
Adjust the pH to 7.4 with NaOH 
 
Agilent Array Wash Buffer I  
SSPE       6x 
N-Lauroylsarcosine      0.005% 
Triton X-100      0,025%    
 
Agilent Array Wash Buffer II 
SSPE       0.06x 
N-Lauroylsarcosine     0.005 % 




Luciferase assay buffers 
 
Passive Lysis buffer 
5x Passive lysis bufer from Promega diluted in H2O 
 
Firefly Luciferase Assay buffer  
Tricine        20   mM    
(MgCO3)4*Mg(OH)2*5H2O     1,07 mM    
MgSO4       2,67 mM 
EDTA         0,1   mM 
DTT       33,3 mM  
Add 0,001 V of 37% HCl to dissolve the magnesium carbonate  
When the solution becomes clear adjust the pH to 7,8 using 5M NaOH 
Add remaining components: 
Coenzym A      270 µM 
D-Luciferin, free acid     470 µM 
ATP       530 µM           
 
Renella Luciferase Assay buffer 
NaCl       1,1 M   
Na2-EDTA      2,2  mM  
KxPO4 (pH 5,1)      0,22 M   
BSA        0,44 mg/ml  
NaN3        1,3  mM  
Adjust pH value to 5,0 and add  
Coelenterazin (dissolved in EtOH)   1,43 mM  
 
KxPO4 (pH 5.1) 
Prepare 1M KH2PO4 solution, adjust the pH to 5,1 using 2 M KOH 
 
Solutions for cell culture 
 
PBS 10x (Phosphate buffered saline) 
NaCl       1,7 M     
KCl       34 mM   
Na2HPO4*2H2O     40 mM   
KH2PO4      18 mM   
Adjust the pH to 7,2 with 1N NaOH    
 
2x Freezing medium for eukaryotic cell lines 
DMEM       40% 
DMSO       20% 
FBS       40%  
 
PLL 250x  
Poly L-Lysin in H2O     5 mg/ml    
Final concentration      0,02 mg/ml 
 
Laminin  
Laminin stock solution     1 mg/ml 
has to be thawed slowly at 2-8°C and diluted in PBS 




Potassium Penicillin     10000 U/ml 
Streptomycin Sulfate     10000 µg/ml 
 
Trypsin-EDTA 10x  
Trypsin       5 g 




Mammalian Cell Lines    
 
PC12   Rat adrenal pheochromocytoma cell line (ATCC) 
(Greene and Tischler 1976) 
 
PC12 tet OFF  PC12 cell line stably expressing tetracycline-controlled 
transactivator (tTA) under neomycine resistance. (Clontech) 
(Greene and Tischler 1976) 
 
HEK 293T  Human embrionic Kidnej immortalized cell line (ATCC) 
   (DuBridge, Tang et al. 1987) 
also designated (HEK 293tsA1609neo)  
 
U2OS   Human osteosarcoma cell line (ATCC) 
   (Ponten and Saksela 1967) 
 




Bacterial Strains  
 
Escherichia coli transformation competent bacteria 
XL1-blue Competent cells     Stratagene 
ElectroMAX DH10B      Invitrogen,  









List of Vectors and Plasmids 
 
Construct       Resistance 
 
 pGemT        AmpR   
pDONR P1 P4       KanR   
pDONR P4 P3       KanR   
pDONR P3 P2       KanR   
pDEST GL3-basic      AmpR 
pDEST_X-ASPlink-TEV1-118-tevS-GV    AmpR   
pDEST_X-ASPlink-TEV119-221-HA   KanR   
pEYFPnuc       KanR   
phRLuc/CMV       AmpR  
pRLuc/SV40       AmpR  
phRLuc/TK       AmpR   
pcDNA3       AmpR   
G5_TATA_Luciferase     AmpR  
tetO_CMV_Luciferase     AmpR   
pCMV_ERT2_tevS_GV_tevS_ERT2   KanR   
pBK_Gal4-VP16      KanR   
pEXPR_3xFlag_hFKBP_TEV1-118    AmpR   
pQCXIX TM-FRB-N-TEV-GV    AmpR   
  
pEXPR_mErbB2_ASPlink_ TEV1-118_tevS_GV  AmpR    
pEXPR_mErbB2_ ASPlink_ TEV119-221-HA  KanR    
pEXPR_mErbB2_Flag     KanR   
pEXPR_mErbB3_ ASPlink_ TEV119-221-HA  KanR   
pEXPR_mErbB3_Flag     KanR   
pEXPR_mErbB4-CYT1_ ASPlink_ TEV119-221-HA KanR   
pEXPR_mErbB4-CYT1_Flag     KanR    
pEXPR_mShc_ ASPlink_ TEV119-221-HA   KanR    
pEXPR_mGrb2_ ASPlink_ TEV119-221-HA  KanR   
pEXPR_PI3K-p85α_ ASPlink_ TEV119-221-HA  KanR   
pEXPR_PI3K-p85β_ ASPlink_ TEV119-221-HA  KanR   
pENTR_L1_bGHpA-pause_L4    KanR   
pENTR_L1_G5_L4      KanR   
pENTR_L4_G5_TATA_L3     KanR  
pENTR_L4_TKprom_L3     KanR   
pENTR_L4_S1-TATA_Intron_L3    KanR  
pENTR_L4_S2-TATA_Intron_L3    KanR   
pGL3_G5_TATA-Intron_ EXT_Luci   AmpR  
pGL3_G5_TKprom_ EXT library _Luci   AmpR  
pGL3_bGHpA-pause_Cis-TATA_ EXT library _Luci AmpR   
pGL3_bGHpA-pause_G5-TATA_EXT library_Luci AmpR   







List of Primers 
 
Cloning primers 
10243 Dec1_s   AGCTAGTTGCTAAGTCTGCCGAGTAG 
9752 Dec2_as   TCGTACATGCATTGACTCGCGTCTAC 
7503 Spot_amine_KS_s GAGGTCGACGGTATCTAGGTGACACTAT 
7505 Spot_SK_as  CTCTAGAACTAGTGGATCGACTCACTATAGG 
10244 Dec1_T3_s  CTCGAGAGCTAGTTGCTAAGTCTGCCGAGTAGAATT 
AACCCTCACTAAAGGGTAGGTGACACTAT 
9754 Dec2_T7_as  CTCGAGACTAGTTCGTACATGCATTGACTCGCG 
TCTACTAATACGACTCACTATAGG 
7692 B1_mGRB2_s  GGGGACAAGTTTGTACAAAAAAGCAGGCTTGACCATG 
GAAGCCATCGCCAAATATGACTTCAAAG 
7693 B1_mGRB2_s   GGGGACAAGTTTGTACAAAAAAGCAGGCTTGGAA 
GCCATCGCCAAATATGACTTCAAAGC 
7694 B2_mGRB2_as  GGGGACCACTTTGTACAAGAAAGCTGGGTCGA 
CGTTCCGGTTCACTGGGGTG 
7695 B2_STOP_mGRB2_as GGGGACCACTTTGTACAAGAAAGCTGGGTCTCAG 
ACGTTCCGGTTCACTGGGGTG 
7725 B1_ACCATG_mSHC_s GGGGACAAGTTTGTACAAAAAAGCAGGCTTGAC 
CATGAACAAGCTGAGTGGAGGCGGC 
7728 B2_Stop_mSHC_as GGGGACCACTTTGTACAAGAAAGCTGGGTCTCAC 
ACTTTCCGATCCACGGGTTGC 
8471 ErbB3 _XhoI_as  GTTCCTCGAGGTAATACATACCCTTGG 
8470 ErbB3_B1_accATG_s ACAAGTTTGTACAAAAAAGCAGGCTCTACCATGAG 
TGCGATTGGGACTCTGCAGG 
8472 ErbB3_XhoI_s  TTACCTCGAGGAACACAGCATGGTG 
8473 ErbB3_SacII_B2_as GAGACCGCGGACTAGTGGGGACCACTTTGTACAAGAA 
AGCTGGGTCAATTCTCTGGGCGTTAGCCTTAGGG 
8551 ErbB3_ClaI_s  AATATCGATGGGTTCGTGAACTGTACCAAG 
10291 B1_G5_s  GGGGCAAGTTTGTACAAAAAAGCAGATGCCTGCAGGT 
10293 B4_G5_as  CCCCCAACTTTGTATAGAAAAGTTGATACCCTCTAGAGT 
12351 B1_bGHpA-pause_s TTACAAGTTTGTACAAAAAAGCAGGCTCTAATTCGCTAGAGGGCCC 
12352 B4_bGHpA-pause_as TTCAACTTTGTATAGAAAAGTTGTTCGATAGAGAAATGTTCTGG 
14079 B4r_G5_s  GGGGCAACTTTTCTATACAAAGTTG ATGCCTGCAGGT 
14080 B3r_G5_TATA_as GGGGCAACTTTATTATACAAAGTTGGAGCTCGGTACC 
14081 B4r_CMV prom_s GGGGCAACTTTTCTATACAAAGTTGCAATATTGGCCATTAGCC 
14082 B3r_CMV prom_as GGGGCAACTTTATTATACAAAGTTGCACTGACTGCGTTAGC 
10234 B4r_TK prom_s  GAGACAACTTTTCTATACAAAGTTGAAATGAGTCTTCGGACCTCGCGG 
10235 B3r_TK prom_as  TCTCCAACTTTATTATACAAAGTTGTTAAGCGGGTCGCTGCAGGGTC 




13530 B4r_S2_bGl-Intr_s GGGGCAACTTTTCTATACAAAGTTGAGGTTTGAGTCCAGC 
TTCCATGTGAGAACTTCAGGGTGAGTTTGGG 
13531 B3r_bGl-Intr_as  CAACTTTATTATACAAAGTTGGTTGCCCAGGAGCTGTAGGAAAAAG 
11057 B4r_Stratagen_Luc_s GGGGCAACTTTTCTATACAAAGTTGCCCACACCTCCCCCTGAACC 
11053 B3r_Stratagen_Luc_as GGGGCAACTTTATTATACAAAGTTGCAGTACCGGAATGCCAAGCTGG 
11058 B4r_pGL2-basic_s GGGGCAACTTTTCTATACAAAGTTGCGCCAGCCCAAGCTACCATG 
11054 B3r_pGL2-basic_as GGGGCAACTTTATTATACAAAGTTGCCAACAGTACCGGAATGCCAAGC 
11059 B4r_Clont pTA-Luc_s GGGGCAACTTTTCTATACAAAGTTGGAGGTACTTGGAGCGGCCGC 
11055 B3r_Clont pTA-Luc_as CAACTTTATTATACAAAGTTGGGTGGCTTTACCAACAGTACCGGAA 
11060 B4r_TransLucent_s GGGGCAACTTTTCTATACAAAGTTGGGCTGCGCAACTGTTGGGAAG 
11056 B3r_TransLucent_as GGGGCAACTTTATTATACAAAGTTGGGTGGCTTTACCAACAGTACCGG 
16014 B4r_Dec1_EXT_s ggggCAACTTTTCTATACAAAGTTGAGCTAGTTGCTAAGTCTGCCGAGTAG 
16015 B3r_Dec2_EXT_as ggggCAACTTTATTATACAAAGTTGTCGTACATGCATTGACTCGCGTCTAC  
10242 B3_Dec1_EXT_s  ggggCAACTTTGTATAATAAAGTTGAGCTAGTTGCTAAGTCTGCCGAGTAG 
9789 B2_Dec2_EXT_as ggggCCACTTTGTACAAGAAAGCTG  
    TCGTACATGCATTGACTCGCGTCTAC 
Sequencing primers 
8474 ErbB3_sequencing CTTGAGCCACTTAATTACCTGCCTGG 
9199 ErbB3_seq1  GGTCGCTGCTTCGGGCCC 
9200 ErbB3_seq2  CCACCACTCTCTGAACTGGACC 
10980 RVprimer3  CTAGCAAAATAGGCTGTCCC 
10764 Luci_as   GGCGTCTTCCATGGTGGCTTTACC 
10977 pENTR_s  CGCGTTAACGCTAGCATGGATCTC 
10978 pENTR_as  GACACGGGCCAGAGCTGCAG 
 
Real time PCR primers 
14032 Luci_qPCR_s  GTCTTCCCGACGATGACG 
14033 Luci_qPCR_as  GTCTTTCCGTGCTCCAAAAC 
14982 GL3_ff-Luci qPCR_s GAGATACGCCCTGGTTCCTG  
14983 GL3_ff-Luci_as  CCACCTCGATATGTGCATCTGT 
10243 Dec1_s   AGCTAGTTGCTAAGTCTGCCGAGTAG 
9752 Dec2_as   TCGTACATGCATTGACTCGCGTCTAC 
9146 b-actin_s  CTTCCTCCCTGGAGAAGAGC 
9147 b-actin_as  ATGCCACAGGATTCCATACC 
9578 Anchored oligo dT-Mix  TTTTTTTTTTTTTTTTTTTTTTTVN 
4542 Random nanomer  NNNNNNNNN 
3213 B1_s   GGGGACAAGTTTGTACAAAAAAGCAGGCTCT 
13446 B2_as   ACCACTTTGTACAAGAAAGCTG  
116201 SP6_TK_s      gagagagaTTTAGGTGACACTATAGAATCCTGCAGCGACCCGCTTAA 




Molecular biology methods. 
Molecular cloning 
PCR products amplified with Taq polymerase were subcloned into pGem-T vector via 
so called TA-cloning. The approach is based on the property of the Taq polymerase to 
add an overhang nucleotide (preferentially adenosine) to the 3’-end of the completed 
PCR product. pGemT vector  is provided in a linearized form with a 5’ tymidine 
overhang which binds complementary to the PCR product. Thereby an efficient 
ligation, catalyzed by the T4 DNA ligase (Promega) is enabled. DNA fragments were 
further excided with the help of restriction enzymes: Type II DNA endonucleases 
(NEB). The vector of interest was digested with the same or compatible enzymes as 
the insert fragment.  Restriction digestion was performed with 3-5 µg of the plasmid 
DNA, 10-20 units of the enzyme at 37°C in the volume of 20 to 100 μl. Suitable 10x 
reaction buffer was selected according to the supplier’s recommendations. DNA 
fragments were separated by electrophoresis in 1% ethidium bromide containing 
agarose gel in 1x TAE buffer and visualized with UV light. In order to extract 
selected DNA fragments, bands of the appropriate size were excised from the gel by 
scalpel and processed with the help of the Gel Extraction Kit (Macherey-Nagel) 
according to manufacturer’s protocol. Purified DNA fragments (the insert and the 
vector backbone in molar ratio of 4:1) were combined with 1 µl of the 10x ligation 
buffer in 10 µl final volume and ligated with the help of T4 DNA ligase (Promega) 
overnight at 4°C or for 1 hour at room temperature. Ligation mix was transformed 
into E.coli strain XL-1 blue or DH-10b. 
Gateway Recombination-mediated cloning 
Most of the constructs were cloned with the help of recombination-based cloning 
systems: The conventional cloning procedure relies on type II DNA endonucleases 
and T4 DNA ligase to specifically cut and join the DNA fragments. It is performed in 
many steps and suffers problems due to suboptimal efficiency of each of those steps. 
In contrary, the Gateway system makes use of site-directed recombination enzymes 
derived from the bacteriophage lambda that are able to insert a desired DNA fragment 
into a construct with much higher efficiency (Hartley, Temple et al. 2000). Detailed 
description of the system can be found online in the product manual book 
(Invitrogen). In order to clone a desired DNA sequence is was PCR amplified using 
primers that carry specific recombination sites: attB1 and attB2. The  PCR product 
was recombined with the pDONR vector carrying attP1 and attP2 sites in a so called 
“BP reaction” catalyzed by the Gateway® BP Clonase™ II enzyme mix, containing 
the viral recombination protein Integrase, the E. coli-encoded protein Integration Host 
Factor and the reaction buffer. Each BP reaction included: 
attB-PCR product  3 µl (unpurified, 10-100 ng) 
pDONR207 (GentaR)  1 µl (100 ng) 
BP clonase II   1 µl   
    5 µl 
The reaction was incubated at room temperature overnight and 1µl was used for the 
electroporation of the DH-10b bacteria. Positive clones were selected by Gentamycin 
resistance and sequenced. Bacteria transformed with unrecombined donor vector did 
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not produce any colonies, because the vector carried a toxic ccdB gene flanked by the 
recombination sites, During recombination, the ccdB gene was replaced by the 
respective insert. Thereby a selective growth of only the properly recombined clones 
was ensured. Constructs carrying the pDONR backbone and the insert are designated 
“entry clones” (pENTR) and serve as shuttle constructs for quick transfer of the insert 
into any expression vector of choice. As a result of recombination between the attB 
and attP sites an attL site is produced:. To generate the final expression construct 
(pEXPR) the attL sites of an entry clone were recombined with the attR sites of the 
so-called destination vector (pDEST). This recombination termed “LR reaction” is 
catalyzed by the Gateway® LR Clonase™ II enzyme mix containing the viral proteins 
Integrase and Excisionase, the Integration Host Factor and the reaction buffer. 
Each LR reaction contained: 
pENTR (25-100 ng/µl) 1 µl 
pDEST (100 ng/µl)  1 µl 
LR colnase   1 µl 
H2O    2 µl 
The reactions were incubated overnight at room temperature and transformed by 
electroporation into the DH-10b competent cells.  
The following sequences were added to the 5’- end of the primers to provide the PCR 
product with the attB1 and attB2 recombination sites: 
attB1  5’- ggggACAAGTTTGTACAAAAAAGCAGGCTCT - insert specific sequence - 3’ 
attB2 5’- ggggACCACTTTGTACAAGAAAGCTGGGTC    - insert specific sequence - 3’ 
Multisite Gateway Recombination mediated cloning 
Recombination-mediated cloning allows assembling of multiple fragments into one 
construct when more then two specific recombination sites are used (Cheo, Titus et al. 
2004). We have applied the MultiSite Gateway® Pro recombination cloning system 
from Invitrogen to generate reporter constructs consisting of three building blocks: the 
cis-regulatory element, the minimal promoter and the EXT reporter. Detailed 
description of the system can be found on the official web page of Invitrogen. The 
principle of the three-fragment recombination is shown in Figure 4. It relies on the 
high specificity with which each att-site is recombined only with its respective 
counterpart. In contrast to the single fragment Gateway recombination, in the 
MultiSite recombination system not all entry clones carry attL recombination sites. 
The entry clone of the middle fragment carries attR sites and recombines with the attL 
containing entry clones of the flanking fragments that at the same time recombined 
with the destination vector. As a result all three fragments are fused together and 
inserted into the vector in the course of one LR reaction.  Fragments of interest were 
PCR amplified with primers introducing appropriate recombination sites, depending 
on the desired position of the fragment: 
 
attB1  5’- ggggACAAGTTTGTACAAAAAAGCAGGCTCT - insert specific sequence - 3’ 
attB4 5’- ggggCAACTTTGTATAGAAAAGTTG - insert specific sequence - 3’ 
 
attB4r 5’- ggggCAACTTTTCTATACAAAGTTG - insert specific sequence - 3’ 
attB3r 5’- ggggCAACTTTATTATACAAAGTTG - insert specific sequence - 3’ 
 
attB3 5’- ggggCAACTTTGTATAATAAAGTTG - insert specific sequence - 3’ 





Figure 4 Schematic representation of the three-fragment recombination cloning. The image is adopted 
from the Multisite Gateway® Pro user manual and shows how three fragments can be cloned 
simultaneously into one construct using multiple specific recombination sites.  
 
The PCR products were recombined with the corresponding pDONR vectors in a BP 
reaction identical to that of the single fragment gateway: 
PCR product    3 µl (unpurified, 10-100 ng) 
pDONR (KanR)   1 µl (100 ng) 
BP clonase II    1 µl             
     5 µl                                      
PCR product (B1-B4)   – pDONR (P1-P4) – pENRT (L1-L4)
  
PCR product (B4r-B3r)   – pDONR (P4r-P3r) – pENTR (R4-R3) 
PCR product (B3-B2)   – pDONR (P3-P2) – pENTR (L3-L2) 
 
The reactions were incubated overnight at room temperature and transformed into 
E.coli strain DH-10b. Positive clones were selected by kanamycin resistance. Plasmid 
DNA was purified, tested by restriction digest and the inserts were sequenced.  
Multisite LR reactions as well as all the other recombination reactions were 
performed in reduced volume relative to that recommended by the manufacturer: 
pENRT (L1-L4) 1 µl 5 fmol 
pENTR (R4-R3) 1 µl 5 fmol 
pENTR (L3-L2) 1 µl 5 fmol   or 6 fmol (3 x 2 fmol) 
pDEST (R1-R2) 1 µl 10 fmol 
LR clonase II Plus 1 µl 
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Prior to recombination the plasmid DNA concentration was measured. Entry clones 
were diluted to the concentration of 5 fmol/ µl and the destination vector to 10 fmol/ 
µl as higher concentrations would reduce the recombination efficiency. The following 
formula was used to calculate the corresponding amount of DNA in nanograms: 













The LR reaction products were transformed into 
DH-10b or Mach1 E.coli strains which were then 
grown at 30°C to protect the insert integrity. 
Propagating this constructs at 37°C or using more recombination permisive E.coli 
strains (e.g.XL-1blue) led to significant reduction in cloning success rate.  
PEG-mediated DNA precipitation 
This method is based on the size-exclusion precipitation due to the polymeric 
properties of the polyethylene glycole (PEG).  It was used for the purification of PCR 
products larger that 300bp prior to recombination cloning or purification of the 
recombination reaction products before electroporation. The samples were diluted to 
100 µl with 10 mM Tris (pH 7,5-8) and 1/2V (50 µl) of the 30% PEG-8000/30 mM 
MgCl2 solution was added. The tubes were vortexed and centrifuged for 15 min at RT 
and 13000 rpm. The supernatant was removed and the DNA was resuspended in TE 
or water.  
Determination of nucleic acids concentration 
Concentration and purity of a nucleic acids solution can be determined by 
spectrophotometry. According to the Lambert-Beer law absorbance of the sample (A) 
is a product of concentration (C), optic path length (l) and a molar absorptivity of the 
substance, so called extinction coefficient (ε): A=Clε. 
An absorbance of a nucleic acid depends on its composition and is a combination of 
the singe base absorbencies. It is commonly accepted to use the following relation of 
optical density to nucleic acid concentration as a valid estimate: 
Double stranded DNA:  1A260 = 50 µg/ml 
Single stranded DNA:  1A260 = 33 µg/ml 
Single stranded RNA:  1A260 = 40 µg/ml 
Where A260 is a unit of absorbance measured at 260 nm which is the wavelength of a 
maximum absorbance for nucleic acids. For an accurate measurement it is important 
that an A260 value falls between 0,1-1 to fit the linear range of a spectrophotometer, 
therefore more concentrated samples were diluted prior to the measurement.   
Sample purity was assessed by measuring the absorbance at 280 and 230 nm. Possible 
contamination of the sample with proteins was ruled out by measuring the absorbance 
at 280 nm, the maximum absorbance wavelength for tyrosine and tryptophane. 
Absorbance at 230 nm was measured to check for the presence of guanidium salt or 
phenol that may be carried over from silica column or phenol extraction procedures 
respectively.  
DNA purity criteria: Samples with A260/A280 between 1,7 and 2 were considered to be 
pure. 
A260/A280 < 1,7   indicates protein contamination  
A260/A280 > 2,0   indicates RNA contamination 
A260/A230 < 2,0   indicates the presence of carbohydrates, salts or organic solvents 
A330 > 0  indicates light scattering by particles and general turbidity of the solution. 
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DNA sequencing and Oligonucleotide synthesis 
DNA sequencing and oligonucleotide synthesis were performed at the Institute DNA 
Core Facility (Department of Neurobiology, MPI for Experimental Medicine, 
Göttingen) under the supervision of Dr. Fritz Benseler. DNA sequences were 
determined by the modified dideoxy sequencing method (Sanger, Nicklen et al. 1977). 
The approach is based on linear DNA amplification in the presence of a single 
sequencing primer, regular free deoxynucleotides and modified dideoxynucleotides 
(chain terminators). Dideoxynucleotides stochastically incorporate into all the 
positions where the corresponding nucleotide is found and terminate the synthesis. A 
mixture of products of different length is separated by capillary electrophoresis. Each 
of four dideoxynucleotides carries a different fluorescent dye, whereby the products 
are also distinctly labeled depending on the identity of the terminal nucleotide. As the 
DNA fragments pass through the capillary their size and fluorescence are determined 
and the sequence is read. 
Plasmid DNA with the concentration of 100-200 ng/µl was usually used as a template 
for sequencing reaction. For some applications like EXT insert screening unpurified 
PCR products derived from RedTaq catalyzed colony-PCR were diluted with water in 
a ratio of 1:10 and sequenced. 
Transformation of chemically competent bacteria 
Aliquots of transformation-competent bacteria (E.coli, strain XL-1blue or Mach1) 
were thawed on ice. 5-10 µl of a ligation or a recombination was added to 100 µl 
competent cells. The bacteria were left on ice for 30 minutes and heat shocked for 30-
45 seconds at 42°C. After 2 minutes on ice 800 µl of cold LB medium without 
antibiotics was added. The bacteria were allowed to recover for 45 minutes at 37°C 
and moderate shaking.  In some cases cells were incubated for 1-1,5 hours at 30°C in 
order to prevent plasmid recombination or loss. After the expression of an appropriate 
antibiotic resistance, 100µl of the bacterial suspension were plated on relevant 
antibiotic-containing LB-agar plate. Remaining bacteria were pelleted by 
centrifugation for 1 minute at 8000 rpm, resuspended in 100-200µl LB/antibiotic and 
plated on a second LB-agar plate. Sterile glass beads were used to evenly distribute 
the bacteria and the plates were incubated overnight at 37°C (or 30°C respectively). 
For retransformation, only 10-30 µl of the competent cells was used and only 5-10 µl 
out of 800 µl bacterial suspension was plated. 
Electroporation of bacteria 
Commercially purchased electrocompetent E.coli, strain DH10B were diluted 1:4 
with sterile 10% Glycerol solution and aliquoted by 20ul per vial. Each aliquot was 
used for one electroporation or further diluted with 10% Glycerol and used for 2 or 
more electroporations. The bacteria were allowed to thaw on ice, 1-1,5 µl of the 
recombination reaction were added and the mixture was transferred into a 1 mm 
electroporation cuvette (BioRad) prechilled on ice. The cells were given an electric 
pulse of 1,8 kV, under 25 μF capacitance and 200 Ω resistance using the 
“GenePulser” electroporation device (BioRad). The cells were then resuspended in 
800 µl LB medium without antibiotics and treated as described above for the heat 







Isolation of plasmid DNA 
Plasmid DNA was prepared from fresh overnight bacterial LB cultures with OD of 2 
to 3. Small scale (mini-prep) and large scale (midi-prep) preparations required 2-4 ml 
and 50-100 ml of the bacterial culture respectively. The preparation was done with the 
help of corresponding kits from Macherey-Nagel or Qiagen. Detailed description of 
the procedures can be found in the handbooks provided by the manufacturers. The 
preparation is based on the main procedures of alkaline lysis and SDS precipitation of 
proteins and genomic DNA (Birnboim and Doly 1979). Due to its smaller size 
plasmid DNA remained in the supernatant and was further purified over an anion 
exchange resin. The DNA was bound to the resin under appropriate high-salt 
conditions was washed with 80% ethanol containing buffer and eluted with 100µl 
5mM or 10mM Tris/HCl pH8,5. In the case of midi-prep the DNA was further 
precipitated with isopropanol and resuspended in the buffer TE (10mM Tris/HCl, 
1mM EDTA, pH8,5) 
Generating frozen stocks of bacterial cultures 
Recombinant plasmid DNA was conserved by freezing bacterial cultures, that where 
transformed with the respective plasmids. After transformation a single clone was 
selected and propagated in LB medium. Three volumes of the log-phase bacterial 
culture were taken per two volumes of the bacterial freezing medium (e.g. 750 and 
500µl, respectively). The samples were mixed and frozen at -80°C. Viable bacteria 
were recovered from the frozen stocks by scratching the frozen surface of the sample 
with a pipette tip and inoculating LB cultures.  
Polymerase Chain Reaction (PCR) 
Polymerase Chain Reaction is a widely used method for selective in vitro 
amplification of a defined DNA sequence. During the procedure a thermostable DNA 
polymerase derived from the thermophilic bacterium Thermus aquaticus (Taq 
Polymerase) replicates selected template DNA molecules multiple times (Mullis, 
Faloona et al. 1986). Since the enzyme is unable of de novo DNA synthesis it requires 
two primer oligonucleotides that bind complementary to the outmost stretches of the 
template. These templates can be extended by the enzyme, to generate a full length 
PCR product. In each round of amplification both strands of the template are 
replicated since one of the primers always bind the sense and the other one to the 
antisense strand. In each subsequent round of amplification newly made PCR 
products are serving as templates leading to exponential amplification kinetics. Taq 
polymerase introduces about 0,8 mismatches per 1 kb per amplification cycle. For 
amplification of long fragments we have used PfuUltra (Stratagene), a modified 
Pyrococcus furiosus DNA polymerase which possess a 3’-5’ exonuclease-dependent 
proofreading activity and exhibits 18-fold lower mutation rate.  
Composition of the PCR reaction:    Final conc. 
10 x reaction buffer  
Template DNA      100 pg-25 ng/reaction 
MgCl2 (included in the buffer or added separately)  1-4 mM 
Deoxynucleotide Mix (dATP, dCTP, dGTP,dTTP)  0,2 mM each 
Forward primer (5-10 pmol/reaction)    0,2 µM 
Reverse Primer  (5-10 pmol/reaction)   0,2 µM 




A PCR reaction consists of 3 main steps: melting, primer annealing and elongation 
which are carried out at different temperatures and are repeated multiple times (in 
cycles). The following rules were used for designing PCR programs: 
Initial denaturation: 2-3 min at 95°C was used to remove any DNA secondary 
structures. This step was extended to 5-10 min when using a hot-start DNA 
polymerase that needs high temperatures to get activated. 
Denaturation:  15-30 sec at 95°C is the first step of the cycle during which the 
complementary strands of the template are melted and become available for the 
primers. 
Annealing: 20-30 sec at a temperature 2-4 degrees lower than the calculated primer 
Tm.  In some cases an optimal annealing temperature was determined empirically by 
using a gradient PCR machine. 
Elongation: was performed at 72°C - the maximal activity temperature for Taq 
polymerase. Elongation time was calculated depending on the template length and the 
enzyme used. DNA polymerases with proof reading activity require roughly 1 min 
elongation time per 1 kb template and non proofreading enzymes - 30 sec/kb. 
Final extension: after desired number of cycles was completed samples were 
incubated another 5-10 min at 72°C to ensure that all the shorter products that might 
have been produced due to incomplete elongation were filled in and completed. 
Designing primer sequences 
Primers were designed to have a melting temperature between 50° and 60°C. 
However in some cases lower temperatures had to be used. Primer melting 
temperature can be roughly estimated by using the following formula:  
Tm= (A + T) 2 + (G + C) 4 
where A,T,G and C are the numbers of corresponding nucleotides in the primer 
sequence. 
For more accurate estimation we have used an online algorithm developed by Warren 
A. Kibbe (Kibbe 2007) and available online at 
http://www.basic.northwestern.edu/biotools/oligocalc.html  
Colony PCR  
Cloning of difficult inserts sometimes requires many clones to be analyzed before the 
one carrying a proper plasmid insert can be isolated. Colony PCR is a time and cost 
effective method for quick screening of a large number of bacterial colonies prior to 
plasmid DNA preparation in order to select only positive ones. The PCR is performed 
directly on a bacterial colony using primers specific for a positive insert or primers 
flanking the insert. In the later case all the inserts would be amplified and the positive 
ones could be distinguished by size after separation of the PCR product by the agarose 
gel electrophoresis. Two 96-well plates were prepared: the first one containing 20 µl 
per well of the complete PCR master mix and the second one containing 100 µl per 
well LB medium supplemented with an appropriate antibiotic. Each colony picked 
with a sterile tooth pick was first dipped into a distinct well on the PCR plate and then 
into a corresponding well on the LB plate. The PCR-plate was incubated at 95°C for 
10 min. At this temperature the bacterial cells would get disrupted to release the 
plasmid DNA and enable amplification. After that the PCR was carried out as usual. 
The LB plate was sealed and kept at 4°C. After the results of the PCR were analyzed 




Agarose gel electrophoresis 
Agarose gels of 1,5% or 3,5% were prepared by dissolving a corresponding amount of 
agarose in 1xTAE buffer and heating the suspension in a microwave for 5-10 min 
until the agarose was dissolved. The solution was cooled to roughly 60ºC to reduce 
evaporation and ethidium bromide was added to a final concentration of 1μg/ml. The 
solution was poured into a gel-casting form, combs were inserted to create pockets for 
sample loading and the agarose was allowed to solidify for 20-30 min. The gel was 
then placed in a chamber 1-3 mm submerged in 1xTAE buffer. To each sample one 
5th volume of the loading dye was added and the samples were loaded into the 
pockets of the gel. A voltage of 4-6 V/cm was applied to induce the migration of 
negatively charged DNA molecules towards the positive electrode leading to their 
size dependent separation. After desired separation was achieved the DNA fragments 
were visualized by the fluorescence of the associated EtBr in 260 nm UV light.  
1,5% agarose gels were used for regular analysis of DNA fragments and purification 
of the DNA fragments for the molecular cloning. 3,5% gels were employed to 
visualize small differences in the PCR product length, in particular for the selection of 
full-length EXT clones by colony PCR. 
Phenol Chloroform extraction and DNA precipitation 
To purify the DNA by phenol chloroform extraction the samples were diluted to 100 
µl and an equal volume of phenol:chloroform:isoamyl alcohol (25:24:1) was added. 
The tubes were vortexed vigorously and centrifuged for 1 min at 13000 rpm to 
achieve phase separation. The upper aqueous phase was removed and mixed with 100 
µl Chloroform. The vortexing and centrifugation steps were repeated. The upper 
phase was removed to precipitate the DNA and the lower phase was discarded.  
DNA was precipitated at room temperature with ethyl alcohol in the presence of 
sodium acetate. Wherefore 1/10th volume of 3M NaAc pH 5,2 and 0,5 µl Glycogen 
was added to each DNA sample followed by vigorous vortexing. Then 2,5 volumes of 
100% ethanol was added, the samples were mixed by vortexing once again and 
centrifuged for 15 min at 13000 rpm at room temperature. The supernatants were 
discarded and the pellets were washed with 70% ethanol, airdried and resuspended in 















Cell biology Methods 
Culturing of eukaryotic cells 
Eukaryotic cells were allowed to grow on 15 cm dishes at 37°C in a humidified 
incubator at 5% CO2. Growth medium was supplemented with GlutaMAX (a 
stabilized dipeptide form of L-glutamine), penicillin, streptomycin and heat 
inactivated serum as described below: 
 
PC12:   DMEM low glucose medium (1 mg/ml),  
1% Pen-Strep, 1% GlutaMAX,  
10% FBS, 5% HS  
PC12 tetOFF: same as for the PC12 
 
U2OS:  McCoy's 5A medium,  
1% Pen-Strep, 1% GlutaMax 
  10% FBS 
 
HEK 293T:  DMEM high glucose medium (4,5 mg/ml),  
1% Pen-Strep, 1% GlutaMax,  
10% FBS 
 
Poly-L-Lysin coating of plastic surfaces 
For better adherence culture dishes for PC12 cells and multi-well assay plates for all 
the cell lines were treated with 0,02 mg/ml PLL in water. After 10 min incubation at 
room temperature the plates were washed twice with sterile water and dried under the 
laminar flow tissue culture hood. Coated plates were stored at 4°C for up to one 
month. 
 
Passaging of eukaryotic cell lines 
The cells were split after reaching 80-90% confluence. The growth medium was 
removed and the plate was washed with room temperature PBS. The cells were 
detached from plastic surfaces by mild treatment with Trypsin-EDTA. The reaction 
was terminated by adding 10 ml of growth medium containing serum and the cells 
were pelleted by centrifugation for 5 minutes at 800 g. The supernatant was discarded, 
the cells were resuspended and 1/10th of the volume was plated onto the coated dishes. 
PC12 cells build strong cell to cell contacts that could not be disrupted as efficiently 
as contacts to plastic. Therefore prior to plating, they were additionally triturated 5 
times through 24G (0,55 mm) needle using 5 ml sterile syringe.   
 
Thawing of eukaryotic cell lines 
Frozen stocks of eukaryotic cell lines were kept aliquoted in 2 ml cryovials at -196°C 
submerged in liquid nitrogen. An aliquot was quickly thawed at 37°C, transferred into 
a falcon tube containing 10 ml prewarmed growth medium and centrifuged for 5 min 
at 800 g. The pellet was resuspended in fresh medium and plated out onto a 15 cm 




Generating frozen stocks of eukaryotic cells  
The cells were preferentially frozen at the stage below 90% confluence. After 
trypsinization the cells were pelleted and resuspended in a small volume of ice-cold 
growth medium. Cells were frozen at a density of approximately 2 million cells per 
1ml. 500 l of the cell suspension was transferred into a cryovial containing an equal 
volume of the ice-cold 2x freezing medium. The samples were mixed gently by 
inverting the tubes and frozen at -20°C. After 2 hours the vials were transferred to -
80°C and after 6-12 hours to liquid nitrogen for long term storage. 
Transfection of mammalian cells 
The cells were typically transfected in 96-well plates for the Luciferase assay. For the 
microarray experiments transfections were performed in solution or in 24-well plates. 
Depending on the cell line and the well size, different number of cells was plated as 
indicated below:  
 
Cell line 96-well 24-well 6-well 
PC-12 tet OFF 50 000 250 000 1 000 000 
PC12 WT 50 000 250 000 1 000 000 
U2OS 15 000 100 000 400 000 
HEK 20 000 100 000 400 000 
 
Lipofectamine 2000 Transfection Reagent (Invitrogen) was used to introduce the 
plasmid DNA into the mammalian cells. Most of the time the cells were transfected in 
96-well flat bottom cell culture plates (Falcon). The original protocol of the 
manufacturer was modified to achieve optimal results. Mini- as well as midi-prep 
quality DNA was used for transfections. Per one well in 96-well plate 10-200 ng of 
plasmid DNA and 0,2 µl of the Lipofectamine 2000 were diluted in 15 µl OptiMEM 
each. The two solutions were combined resulting in 30 µl volume and incubated for 
20-30 min at room temperature. The growth medium was completely removed and the 
cells were covered with the 30µl per well OptiMEM containing the DNA-
Lipofectamine complexes. After 2 hours the transfection medium was exchanged for a 
regular growth medium. Alternatively the growth medium was supplemented with 
twice the amount of serum and 30 µl per well were added on top of the transfection 
medium to reach the final volume of 60 µl and the regular final concentration of 
serum. 
Transfection in solution 
For the microarray experiments PC12 tet OFF cells were transfected in suspension. 
The cells were trypsinized, triturated through a 24G needle 5-10 times to remove any 
cell clumps and the cell number was determined. Desired number of cells was pelleted 
by centrifugation for 5 min at 800 g and resuspended in DMEM, 1% HS to reach a 
cell density of 100 000 cells per 100 µl. Depending on the cell number the following 
amounts of transfection components were used: 
  
   per 100 000 cells  per 2 000 000 cells 
Lipofectamine 2000 0,4 µl     9 µl   
Renilla Mix   0,2 µl (40 ng)   4,5 µl (900 ng) 
plasmid DNA  100 ng    6 µg 
OptiMEM  5 µl + 5 µl   10 µl + 10 µl 
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The DNA and the Lipofectamine 2000 reagent were diluted in one half of the 
OptiMEM volume each, mixed and combined together. The Lipofectamine-DNA 
complexes were allowed to form for 20 min at room temperature and were then added 
to the cell suspension. The tubes were incubated at 37°C for 4 h without shaking. 
Transfected cells were centrifuged to remove the transfection mixture, resuspended in 
fresh media mixed and plated out according to the experimental design.  
Luciferase reporter gene assay 
Measurements of the firefly luciferase (ff-Luciferase) activity are often normalized to 
the readings of a different reporter gene, e.g. Renilla Luciferase (Renilla) expressed 
under a constitutively active promoter. This type of normalization helps to correct for 
the differences in cell numbers, transfection efficiency, RNA and protein expression 
and general well being of the cells from well to well. We have used a combination of 
three different plasmids to express the Renilla luciferase under the control of three 
different promoters (Renilla Mix). The amount of plasmid DNA was adjusted to 
balance the expression levels from each of the promoters (SV40:TK:CMV = 10:2:1). 
The Renilla Mix was cotransfected along with any firefly reporter gene assay. In order 
to monitor the transfection efficiency an equal amount of pEYFPnuc, a plasmid for 
CMV-driven expression of the nuclear localized Enhanced Yellow Fluorescent 
Protein was included. (Renilla Mix : pEYFPnuc = 1:1) 
Composition of the Renilla Mix:      
pRLuc/SV40   100 µg      
phRLuc/TK   20 µg   
phRLuc/CMV   10 µg   
pEYFPnuc   130 µg  
10 mM Tris pH8,5 up to 1,3 ml   
Final conc. 200 ng/µl (100ng/µl Renilla Luciferase constructs, 100ng/µl EYFPnuc) 
Luciferase assays were always performed in 96-well format. Per well 50-200 ng of 
plasmid DNA was transfected including 0,1 µl (20 ng) of the Renilla Mix and 10-50 
ng per construct of other plasmids. To ensure the statistical reliability of the results 
each assay was performed in 4-6 replicates, usually 4-6 wells on the same plate 
transfected with the same DNA-Lipofectamine master mix. Depending on the design 
of the experiment, transfected cells were allowed different time to express the 
recombinant proteins and reporter genes. After the experiment was finished the 
medium was removed and the cells were lysed with 30 µl per well Passive Lysis 
Buffer (Promega). The plates were incubated for 15 min at room temperature with 
slight shaking (200 rpm). Lysates were assayed immediately or frozen at -20°C. Prior 
to the measurement the lysates were transferred into a black plastic microtiter plate to 
reduce the light signals leakage and cross mixing due to light reflection. The dual 
luciferase assay measuring the bioluminescence of both Firefly and Renilla 
Luciferases was carried out with the help of the Microplate reader Mitras LB940 
(Berthold Technologies) and the associated software MicroWin 2000. 
To each well 75 µl of the ff-Luciferase substrate was injected, the reaction was 
allowed to stabilize for 2 sec and the light signals were collected over the next 10 sec. 
Then 75 µl of the Renilla substrate was injected and after a 2 sec pause the 10 sec 
measurement was performed. The Firefly and the Renilla luciferase have high 
substrate specificity and do not cross-activate. Moreover ff-Luciferase activity is 
inhibited by the pH conditions of the of the Renilla substrate.  
The data were exported from MicroWin2000 and analyzed with the help of Excel. 
The Firefly readings were divided by the corresponding Renilla readings producing 
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values in relative luciferase units (RLU). An average over the 6 replicates was taken 
and the standard deviation was calculated. 
Preparation of the microarray target 
RNA isolation  
To prepare RNA from the cell culture the medium was removed, the cells were 
quickly washed with PBS and lysed by adding Trizol Reagent. In case of 96-well 
plates the washing step was omitted. Trizol Lyzates were transferred to 2ml eppendorf 
tubes and vortexed to ensure complete lysis. 1/5th of a volume of Chloroform was 
added. The samples were vortexed thoroughly and centrifuged for 15 min at 4°C, 12 
000 g.  
The following amounts of the Trizol Reagent and Chloroform were used 
 
Plate Area Cell number Trizol Chloroform 
96-well 0,3 cm2 50 000 125 µl 25 µl 
24-well 2 cm2 250 000 500 µl 100 µl 
6-well 10 cm2 1 000 000 1 ml 200 µl 
 
Trizol Reagent is a solution of phenol and guanidine isothiocyanate that lyses the cells 
by dissolving the membranes and upon addition of chloroform separates into two 
phases: organic and inorganic. RNA remains exclusively in the aqueous (inorganic) 
phase (Chomczynski and Sacchi 1987). Proteins that are contained in the organic 
phase and genomic DNA that accumulates at the interphase can also be recovered 
within the same preparation (Chomczynski 1993). RNA containing aqueous phase 
was supplemented with equal volume of 70% ethanol and further purified over an 
RNeasy column (Qiagen) including an on-column DNase treatment, according to the 
manufacturer’s protocol. Both Trizol extraction and RNeasy column are known to 
yield RNA of high purity that is free of genomic DNA. However samples derived 
from transiently transfected cells contain considerable amount of plasmid DNA that is 
smaller in size and unlike genomic DNA can not be efficiently removed by these 
methods. Even after an on column DNase digestion we have always observed a slight 
plasmid DNA contamination in our RNA samples detected by PCR at about 40 
cycles. To minimize this contamination purified RNA was additionally treated with 3 
units of RQ1 DNase in solution for 30 min and repurified over an RNeasy column.  
RNA precipitation 
The RNA was precipitated with ethyl alcohol and ammonium acetate salt. To 100 µl 
RNA 50 µl of 7,5 M NH4Ac and 0,5 µl of Glycogen solution (20 mg/ml) was added. 
The RNA was then precipitated by adding 450 µl of the 100% EtOH. The samples 
were mixed thoroughly and centrifuged at room temperature for 30 min at 12000g. 
Glycogen precipitates at the same conditions as nucleic acids and serves as a carrier 
that prevents RNA loss during precipitation. Presence of the carrier makes the pellet 
visible, the precipitation procedure more reliable and does not compromise 
downstream enzymatic reactions such as reverse transcription, PCR or sequencing. 




First Strand cDNA synthesis 
First strand cDNA was generated from 0,5 – 1 µg total RNA using Superscript III 
reverse transcriptase (Invitrogen). Equal amounts of RNA for each sample were 
precipitated and resuspended in 4,5 μl RNase free water, 1 μl (120 pmol) of the 
random nanomer primer (#4542) was added to the final volume of 5,5 μl. The samples 
were denatured for 2 minutes at 70°C and placed on ice. Then other components were 
added: 
5x First Strand buffer     2 µl    
0,1 M  DTT      1 µl 
dNTP mix (10mM each)    0,5 µl 
Superscript III reverse transcriptase (200 U/μl) 1 µl___ 
Final volume      10 µl 
 
The samples were incubated for 10 min at 25°C to allow for the annealing of random 
nanomer primers, then for 1 hour at 50°C for the RNA dependent DNA synthesis. 
After that the enzyme was heat inactivated for 5 min at 85°C. The cDNA was diluted 
1:8 with water and used for PCR amplification. 
To monitor the cDNA quality with respect to plasmid DNA contamination for each 
sample a negative control was performed where all the reaction components were 
included except the reverse transcriptase (abbreviated as –RT control). 
Quantitative real-time PCR 
Real time PCR was used to determine the relative expression level of an EXT reporter 
for the experiment where only one EXT reporter construct was used or to monitor the 
amplification kinetics and asses the sample quality of an EXT reporter mixture that 
was further used for a microarray hybridization. Quantification of the PCR product 
was performed using Power SYBR Green PCR Master Mix (Applied Biosystems). 
SYBR Green intercalating cyanine dye contained in the master mix binds double 
stranded PCR products as they are being generated and makes them detectable by 
fluorescence. The reaction mix was assembled as follows: 
 
cDNA (1:8 diluted)   4 μl 
SYBR Green PCR Master Mix 6 μl 
Forward primer (50pmol/ μl)  0,1 μl 
Reverse primer (50pmol/ μl)  0,1 μl 
 
The annealing temperature for the Dec1/Dec2 primer pair was optimized to 60°C by 
gradient PCR. The following amplification program was used: 95°C – 10min, cycle: 
95°C – 30 sec, 60°C – 30 sec, 72° - 31 sec (fluorescence reading step), 45 cycles. 
For the preparative PCR the amplification was stopped shortly before the last sample 
had reached saturation (at about 35-40 cycles).  
In Vitro Transcription (IVT)  
The IVT was performed with the help of the T7 MEGAscript Kit (Ambion) that 
makes use of the bacteriophage T7 RNA polymerase to transcribe the DNA 
downstream of the T7 promoter. EXT PCR products amplified with the Dec1 
(#10243) and Dec2 (#9753) primers carry T7 promoter just before the Dec2 binding 
site. Unpurified PCR product amplified with the RedTaq DNA Polymerase (Sigma 
Aldrich) or SYBRGreen PCR Mix (Applied Biosystems) was used as a template for 
the in vitro transcription. In the course of this reaction 5-(3-aminoallyl)-modified UTP 
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was incorporated into the newly synthesized RNA which was required for its 
fluorescent labeling for the microarray hybridization.  
The IVT reaction volume was downscaled relative to the manufacturer’s protocol: 
 
PCR product    4µl 
10 x  Reaction Buffer   1 µl 
ATP (7,5 mM)   1 µl 
CTP (7,5 mM)    1 µl 
GTP (7,5 mM)   1 µl 
UTP (7,5 mM)   0,5 µl 
5-(3-aminoallyl-UTP) (50 mM) 0,75 µl 
T7 RNA Polymerase   1 µl  
 
The reactions were incubated overnight at 37°C. Heated lid at 42°C was used to 
prevent evaporation which significantly increased the IVT yield. After that, the 
template DNA was degraded by adding 1 µl of Turbo DNase to each sample and 
incubating at 37°C for 15 min. Typical yield of the EXT-IVT comprised 5-10 µg of 
short aminoallyl-modified RNA 111 bases in length. The RNA was purified over an 
RNeasy column (Qiagen) using a modified protocol described below. 
Purification of short RNA 
The IVT product was purified via an RNeasy mini Kit (Qiagen). In order to ensure the 
efficient recovery of small RNAs the manufacturer’s protocol was modified. The 
volume of all samples was adjusted to 100 µl with RNase free water. Per each sample 
100 µl buffer RLT was added and the samples were mixed. Then 400 µl of 
isopropanol was added, the samples were quickly mixed by vortexing, immediately 
transferred to the RNeasy columns and centrifuged for 15 sec at 10 000 g. The 
membranes were washed twice with 500 µl RPE buffer and dried by centrifugation 
for 2 min. The RNA was eluted in two steps with 50 µl H2O each time to maximize 
the RNA yield. 
Labeling of the microarray target 
To generate a probe for a microarray, hybridization purified RNA carrying the 
aminoallyl-modified nucleotides (aaRNA) was coupled to the cyanine dye esters: Cy3 
or Cy5. For each labeling reaction 5-10 µg of the aaRNA was lyophilized and 
resuspended in 4,5 µl Coupling buffer (Ambion). One tube of the Cy3- or Cy5-
monoreactive dye (Amerscham) was dissolved in 55 µl DMSO and 5,5 µl was added 
to each sample. After a 30 min incubation at room temperature in the dark, the 
reaction was neutralized by the addition 2,3 µl 4M Hydroxylamine (Ambion). The 
tubes were incubated in the dark for another 15 minutes and the RNA was purified via 
the modified RNeasy protocol as described above. The dye incorporation efficiency 
(E) was calculated as follows:      
)µl/µg( ConcRNA 
(pmol/µl) Dye
(pmol/µg) E    
A successful labeling usually resulted in a dye incorporation of 50-100 pmol/µl.  
Such samples were used in the microarray hybridization.  
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Microarray hybridization and analysis 
Hybridization of Agilent microarrays 
The amount of the target was adjusted to the amount of the dye and not the amount of 
RNA in order to compensate for the slight differences in labeling efficiency from 
sample to sample. The target contained 10-30fmol of the Cy-dye per EXT, which 
depending on the labeling efficiency constituted 0,1-0,5ng RNA per EXT. We have 
used modified 2xHybridization Buffer containing salmon sperm DNA and yeast 
tRNA to increase the hybridization stringency.  
 
The hybridization mix for the 8-plex Agilent microarray contained: 
2 x Hybridization buffer   25µl 
10 x Blocking agent   5 µl 
Formamide (f.c. 15%)   7,5 µl 
Target     12,5 µl 
Final volume    50 µl 
 
The samples were mixed by pipetting, centrifuged for 1 min at 13 000 rpm and 40µl 
was loaded per subarray. The arrays were hybridized at 65°C for 20 hours. 
The arrays were opened submerged in 250ml Wash buffer-1 prewarmed to 37°C. Up 
to 4 array at a time were washed at RT for 1 min in 250ml Wash buffer-1 and for 
another 1 min in 250ml of the Wash buffer-2. The arrays were dried by dipping for 30 
seconds in 250ml Acetonitril.   
Hybridization of NimbleGen microarrays 
The NimbleGen arrays were hybridized according to the standard protocol provided 
by the manufacturer however using the Cy-dye labeled aaRNA and not DNA as a 
target. The amount of the target for 4-plex NimbleGen microarays was calculated in 
the same way as for Agilent arrays. The arrays were hybridized at 48°C (for some 
control experiments at 50°C). Washing procedures were carried out using the 
NimbleGen wash buffer Kit following the manufacturer’s recommendations. The 
slides were dried by dipping for 30 sec in Acetonitril and scanned with the help of the 
GenePix 4200A microarray scanner. 
Hybridization of the self spotted microarrays 
Self spotted microarrays were produced at the DNA microarray facility, Medical 
Faculty, University of Göttingen (http://www.microarrays.med.uni-goettingen.de). 
EXT oligonucleotides were amplified with spotting primers (#7503, #7505). PCR 
products were purified with the ChargeSwitch PCR Clean-Up Kit (Invitrogen) and 
spotted on the surface of Codelink Activated Slides (Amersham) in 50mM Na3PO4 
buffer at pH8,5. The forward primer carried an amine modification that was used for 
the crosslinking of the corresponding DNA strand to the surface of the slide. 
Therefore, the sense strand of the PCR product remained on the spot while the 
antisense strand was washed away. The arrays were hybridized at 50°C using Agilent 
hybridization chambers and gasket slides in Affymetrix hybridization buffer 
containing 50% Formamide. The arrays were submerged in 2x SSC, opened and then 
washed for 5 min in 2x SSC, 0,1% SDS, then for 1 min in 0,2% SSC and for another 
1 min in 0,1% SSC. The slides were dried in the flow of nitrogen and scanned.  
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Microarray Scanning and Data Extraction 
All arrays were scanned with 5 µm resolution. The Cy3 dye was excited at 532 nm 
and the Cy5 at 633 or 635 nm depending on the laser available. The fluorescent light 
was collected at 550-610 nm (Cy-3) and 650-750 nm (Cy-5). Self spotted and Agilent 
microarrays were scanned using Microarray Scanner G2565AA enabled by the Scan 
Control software (Agilent). Two scans were performed at 10% and 100% sensitivity 
of the photomultipliers. The two image files were processed by the Agilent Feature 
Extraction Software using an eXtended Dynamic Range (XDR) function to generate 
data with high resolution (potentially 5 orders of magnitude). 
The NimbleGen arrays were scanned using the Agilent scanner for the control 
hybridizations and the GenePix 4200A microarray scanner (Axon Instruments) for the 
biological experiments. The scanning process was controlled by the GenePix Pro 
software and the data were extracted using the NimbleScan software (Roche 
NimbleGen). 
Microarray Data Analysis 
Raw data analysis was performed by Sven Wichert (MPI for Experimental Medicine, 
Göttingen) with the help of “R” statistical computing environment (http://www.r-
project.org). The overall intensities of the microarrays were normalized using the 
RMA algorithm implemented in the R package. The average probe intensities were 
calculated across 4-8 replicate features depending on the design of the array. Average 
Cy5 signals represented the relative EXT expression levels and were normalized to 
the Cy3 signals originating from the plasmid DNA input. Plasmid input/Cy3 
normalized EXT/Cy5 expression data were either given as relative differences (fold-
changes) between samples or as arbitrary normalized expression values. 
 
 
Synthesis and cloning of the EXT reporter library 
EXT library synthesis 
The synthesis of the EXT oligonucleotide library was carried out by the DNA Core 
Facility (MPI for Experimental Medicine, Göttingen) using standard DNA 
oligonucleotide synthesis chemistry. To create a complex oligonucleotide mixture, the 
synthesis followed a mix and divide strategy. After the synthesis of the 15-mer 3’ 
invariable region, the sample was split into 8 portions each continuing the synthesis 
with a different sequence of 4 nucleotides. We have defined 8 specific 4-nucleotide 
combinations so called “words” that were used in this synthesis: CTTT, CAAA, ACAT, 
TCTA, TACT, ATCA, TTAC, and AATC. The resins carrying the oligonucleotides were 
mixed and subdivided again to continue with the 8 words at the next position. The 
cycle was repeated to introduce 5 randomly incorporated words in a row. Then a 
symmetrical 9-mer core sequence was generated by splitting the samples into 2 equal 
portion after each next nucleotide (WSWSSSWSW, where W=A/T and S=C/G). The 
synthesis was completed by 5 additional words and a 5’ invariable region. The 
resulting mixture of the 77-mer oligonucleotides was purified by HPLC and provided 
at a concentration of 50 pmol/µl. The synthesis strategy is illustrated in Figure 6 in 
the Results section. 
 40
 
Cloning of the pENTR EXT library 
The EXT oligonucleotide library was diluted 104 times and PCR amplified for 30 
cycles with the primers #10244 and #9754 complementary to the 5’ and 3’ invariable 
regions. The PCR product was then reamplified for 10 cycles with another primer pair 
(#10242 and # 9789) to introduce the B3 and B2 recombination sites. Resulting PCR 
products were used for the generation of the pENTR shuttle clone library by 
recombination cloning. The BP reaction was set up in 20µl volume containing 4 µl 
pDONR P3 P2 vector, 12 µl PCR product and 4µl BP clonaseII enzyme mix. After an 
overnight incubation at 25°C the recombination product was purified by phenol 
chloroform extraction and ethanol precipitation, resuspended in 5µl H2O and 
electroporated into 100µl undiluted DH-10b bacterial. The bacteria were allowed to 
recover in 2ml SOC medium for 1 hour and 1/20th of the bacterial suspension was 
plated to estimate the clone numbers. Remaining bacteria were transferred into 200ml 
LB medium, 50µg/ml Kanamycin and allowed to grow at 37°C for 4 hours. The 
culture was then centrifuged and the pellet was used for a midi-prep plasmid DNA 
preparation (Qiagen). The clone number in the preparation was estimated to roughly 
100.000 clones. Several hundred colonies were screening by colony PCR with 
pENTR_s (#10977) and Dec2 (#9752) primers. The PCR products 280bp in size were 
separated on 3,5% agarose gels and 50% of the clones were discarded due to reduced 
insert length. From the other 50% of the clones some of the unpurified PCR product 
was diluted 1:10 with water and sequenced using pENTR_s primer (#10977). 
After sequence verification 50-60% of the clones were selected that carried perfect 
full length inserts. For those clones mini-prep plasmid DNA was prepared and the 
bacterial stocks were generated in 96-well format. The overall cloning success rate of 
the entry clone EXT library should be considered around 25%.  
Cloning of the G5 EXT library 
The entry clone EXT library (L3/L2) in the form of the midi-prep DNA was 
subsequently used in an LR reaction with the G5-element (L1/L4), the TK promoter 
(R4/R3) and the pDEST_GL3_Luci to generate a library of GV responsive EXT 
reporter constructs (G5_TK_EXT-lib). The recombination reaction was set up in 20µl 
with 40fmol of the destination vector and 20fmol of each of the entry clone constructs 
and incubated at RT overnight. The LR reaction was purified by PEG precipitation 
and transformed into 100µl DH-10b. All the bacteria were transferred into 200ml 
LB/ampicillin and grown for 4 hours at 37°C. Different amounts of the suspension 
were plated out to estimate the density and the rest of the suspension was kept at 4°C 
overnight. The next day the bacteria were plated on square (25x25cm) agar plates 
containing 50µg/ml Carbenicillin and cultured overnight. The colonies were picked 
and transferred into 96-well plates containing 100µl per well LB/carbenicillin by the 
QPix Colony Picking Robot (Genetix). The bacteria were grown overnight and frozen 
at -80°C. The clones were screened by colony PCR using 0,5µl of the culture as a 
template. The inserts were amplified with the Dec1 (#10243) and Luc_as (#10764) 
primers and the PCR products were sequenced with the antisense primer (Luc_as, 
#10764).  
About 2000 colonies were screened and 60% were discarded after the PCR analysis 
due to the size problem (30%) or failed PCR (30%). Among the remaining 40% only 
18% were found to be perfect. 33% had non unique sequences, 27% failed in the 
sequencing reaction and 23% were missing 1-6 nucleotides. Final cloning success rate 
of the G5_TK_EXT-library can thus be considered to be at around 6%. 
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Cloning of the Cis-element EXT reporter constructs 
Cis-regulatory elements were amplified from the available Luciferase reporter 
constructs along with the minimal promoter and a part of the 5’ plasmid sequence to 
generate the Cis-element EXT reporter constructs. Depending on the template, 
different primer pairs were used carrying B4r and B3r recombination sites. Most of 
the cis-elements were derived from the Clontech’s Pathway Profiling System 
(primers: #11059, #11055) and Panomics reporter constructs (primers: #11060, 
#11056). Each of the cis-element entry clone was recombined with three different 
sequence verified pENTR_EXT plasmids in one rection. A total of 6 fmol of the EXT 
entry clone was used in recombination which makes 2 fmol per each each EXT. For 
each cis-element, 6-8 clones were sequenced to isolate the clones with different EXT 
sequences. 
Transfections for Microarray Experiments 
Transfections for microarray experiments were performed with adherent cells or 
trypsinized cells in suspension. In the latter case the cells coming from several 
different transfections were mixed and cultured under identical experimental 
conditions. For every microarray 106 cells were transfected with 5ng of each of the 
EXT reporter constructs. From 20 to 100 different plasmids were used in one 
transfection. For GV titration experiment as little as 2ng DNA per construct was used 
for the EXT pull exposed to the constant amount of GV. Reporter plasmids at mini-
prep DNA quality were premixed and used for transfection to minimize the pipetting 
errors. Plasmids required for the protein-protein interaction assays were derived from 





























List of cis-elements and associated EXT reporters 
 
Cis-element Min Prom   EXT Number    EXT sequence 
NFkB TATA u109 AATCAATCCAAACTTTCTTTTGACGGTCACTTTACATTCTACTTTTCTA 
NFkB TATA/TAL u110 ATCAACATTCTACTTTTCTAAGAGCGAGATCTATACTTCTATTACACAT 
NFkB TATA/TAL u111 TACTACATACATACATTCTATCACGCTCTTCTAATCACTTTCTTTTTAA 
CRE TAL u112 ACATCAAATTACCAAATCTATCAGGGACATCTACAAAACATCTTTTTAC 
CRE TAL u113 ACATTACTTCTAAATCACATACTGGGTCTACATCTTTCTTTCAAATTAC 
CRE TAL u114 AATCTACTTACTATCACTTTAGAGGCTGTCTTTTCTACTTTACATTTAC 
E-box TATA u115 CAAAATCAACATATCATCTAAGAGGCTGTTCTAAATCATCACAAAATCA 
E-box TATA u116 TACTAATCTCTAAATCCTTTTGTCGGTGACTTTTACTCAAACTTTAATC 
E-box TATA u117 TCTACTTTACATCTTTACATACAGCCTCTACATTCTAATCATTACTACT 
   - TATA u118 ATCAATCATTACAATCCTTTTGAGCGACACTTTCTTTAATCAATCTACT 
   - TAL u119 CAAAAATCCAAATCTAACATACTCCCTGTACATTCTAATCATCTAACAT 
IRF-1 TATA u121 AATCTACTCTTTACATCTTTTGACCGAGTCTTTCTTTTCTATTACTCTA 
IRF-1 TATA u122 TACTACATCTTTATCAACATACTGGCTGTACATTCTATACTTACTTTAC 
Stat3 TATA u123 CTTTACATACATTCTATCTATGACGGAGTTCTAATCATACTTTACCAAA 
Stat3 TATA u124 CAAACAAATCTATCTAACATACACGGTCTACATTACTTACTTTACAATC 
Stat3 TATA u125 CAAATTACACATCTTTTCTATGAGCCTGTTCTACAAAATCAATCATCTA 
GAS TATA u126 TTACACATCTTTCTTTCTTTACTCCGTGTCTTTCTTTCTTTATCATCTA 
GAS TATA u127 CAAACTTTATCAATCACAAAACTCGGTGACAAACTTTATCAACATCAAA 
GAS TATA u128 ACATAATCTCTAACATTCTAACAGGGTGTTCTACAAATACTTTACTACT 
ISRE TATA u129 ATCATCTACAAACTTTACATAGACCGACAACATTCTATACTTCTATACT 
ISRE TATA u130 AATCATCATACTTCTAACATTGAGGCAGAACATTACTTCTATACTCTTT 
ISRE TATA u131 TTACCTTTACATAATCACATAGTCCCTCAACATTTACAATCACATTCTA 
NFAT TATA u132 ACATATCATACTTCTACAAATGACCGTGACAAACTTTACATTACTTCTA 
NFAT TATA u133 ATCAACATCTTTACATCTTTAGAGGGACTCTTTTACTTACTCTTTACAT 
NFAT TATA u134 AATCAATCTCTATCTATCTATGTCCCACATCTATACTTCTATTACCAAA 
Myc TATA u135 ATCAATCATCTAATCACAAAACTGGCTGTCAAAACATACATAATCTTAC 
Myc TATA u136 ACATACATTTACCAAACAAATGTGCGTGTCAAACAAATCTACTTTTTAC 
Myc TATA u137 CTTTTTACCAAACAAATCTAAGAGGCTGATCTATCTACAAAAATCTTAC 
p53 TATA u138 TTACTACTCTTTTACTCTTTTCACCGTCACTTTTACTTCTATCTACAAA 
p53 TATA u139 AATCCTTTACATCAAACAAATCAGGGTGTCAAATTACACATTACTTACT 
p53 TATA u140 TACTTTACACATATCACTTTACAGCGAGACTTTTTACTTACTACTATCA 
Rb TATA u141 TTACAATCATCACTTTCAAAACTCCGTGACAAATACTATCATACTATCA 
Rb TATA u142 ATCAAATCTACTACATCAAAACTGGGTCACAAACTTTTCTATTACCAAA 
Rb TATA u143 ATCATCTAATCAAATCACATTGAGGCACTACATAATCCTTTCAAAAATC 
AP1 TAL u144 TCTAACATCTTTACATCTTTACTCGGACACTTTCTTTTTACATCATACT 
AP1 TAL u145 CTTTATCAAATCCTTTTCTATCACGCTCTTCTAATCACTTTACATATCA 
AP1 TAL u146 AATCTACTTACTATCACTTTTCAGCCAGTCTTTACATTACTTCTACAAA 
GATA TATA u147 TCTAACATCAAACAAACTTTTCACCGAGACTTTAATCACATTACTCTTT 
GATA TATA u148 CTTTATCAACATAATCCAAATGTCGCACTCAAAATCACAAACAAAACAT 
GATA TATA u149 ATCATTACTCTATACTACATTCAGGCTGTACATTACTCAAACAAACTTT 
HRE TATA u150 TCTAATCAACATAATCACATTGAGGGACTACATTTACCTTTTTACTCTA 
HRE TATA u151 ACATATCATTACATCAACATTCTGCCTCAACATTACTATCAACATACAT 
HRE TATA u152 TACTAATCTCTAAATCTCTAAGTGGGTGATCTACAAAATCAACATTCTA 
E2F TATA u153 CTTTTCTATCTAAATCACATACAGCCTCTACATTCTAAATCATCAAATC 
E2F TATA u154 TCTACAAATCTATCTACTTTTGACCCAGTCTTTTCTAAATCACATAATC 
E2F TATA u155 TACTCTTTACATTACTACATACTCCGTCAACATACATTCTACTTTACAT 
GRE TAL u157 ACATACATCTTTCAAACTTTACACGCTGACTTTCAAATCTATTACTCTA 
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GRE TAL u158 TTACTACTTTACCTTTTCTATCACCGAGATCTACAAAACATTACTACAT 
HSE TAL u159 CAAAATCAATCAACATACATTGAGGGTCTACATTACTTTACACATACAT 
HSE TAL u160 TTACCAAATACTTTACACATACACGGAGTACATATCATCTATACTTACT 
SRE TAL u163 ATCATCTATACTACATACATACACGCTCAACATTACTATCAATCAACAT 
SRE TAL u164 TACTATCACAAACTTTACATAGAGCCTCAACATCTTTACATTACTCAAA 
MEF-1 TATA u165 AATCACATAATCTCTAACATTGTGGCACTACATTCTAATCAACATTTAC 
MEF-1 TATA u166 ATCATTACAATCACATACATTCTGGCTGTACATCAAATCTATCTATACT 
MEF-1 TATA u167 TACTAATCCTTTTCTATCTATGACCCTGTTCTATTACAATCCTTTATCA 
MEF-3 TATA u171 TTACTCTACTTTAATCACATTGTGCGTCTACATACATTCTAACATACAT 
MEF-3 TATA u172 TTACTACTTCTATTACTCTATGAGGGTCATCTAACATTTACTCTAACAT 
MEF-3 TATA u180 ATCATCTACAAAACATCAAATCTGGGACACAAAAATCCTTTCAAAACAT 
ELK1 TATA u174 TTACATCATTACTTACACATAGAGGGTCAACATTTACCTTTATCATACT 
ELK1 TATA u175 ATCACTTTTCTAAATCACATTCTGGGTCTACATTCTAACATTACTATCA 
RxR TATA u177 CAAAATCATCTAATCATCTATGTGGCAGATCTAATCATACTACATCTTT 
RxR TATA u178 AATCACATTTACACATTCTAAGTGCCAGATCTACAAAATCAAATCTTAC 
RAR TATA u181 ACATTACTTTACATCATCTATGTGCGTGATCTAACATATCAATCAAATC 
RAR TATA u184 CTTTACATAATCCTTTCAAATCTGCCTCTCAAATACTTCTATCTACTTT 
RAR TATA u185 ATCACAAATCTATACTTCTAACTGGGTCTTCTATCTAATCAAATCACAT 
EGR3 TATA u186 AATCTCTACAAAAATCCAAATGAGGCACTCAAAACATCAAATTACATCA 
EGR3 TATA u187 ACATATCACTTTAATCACATTCAGGGACTACATCAAATACTCTTTAATC 
EGR3 TATA u188 ACATACATTACTTCTAACATAGTCCCTCAACATTTACCAAATCTAATCA 
PR TATA u189 ACATTTACCTTTTTACACATTGACCGTCTACATTACTTTACCTTTAATC 
PR TATA u190 CTTTTACTACATAATCACATTGAGCCACTACATTCTATCTAACATCAAA 
PR TATA u191 CAAATTACTCTACAAATCTAACACCCTGTTCTATCTATCTAACATATCA 
ER TATA u193 CTTTACATTCTATTACTCTAACTCCCAGTTCTATACTTTACAATCACAT 
AR TATA u195 CAAATACTAATCCTTTTCTATCAGGGAGATCTATACTACATTACTTACT 
AR TATA u196 ACATTACTACATTACTACATTCTCCGAGAACATTACTAATCTTACCAAA 
AR TATA u197 AATCATCATCTATTACCAAATGTGCGACTCAAAATCAAATCTTACCAAA 
RxR2 TATA u198 ACATTCTAACATTACTCTTTAGTCGGTCACTTTACATATCAATCATTAC 
RxR2 TATA u199 CAAAACATCTTTAATCACATTGTGGCTCTACATCTTTACATAATCACAT 
RxR2 TATA u200 AATCATCAAATCACATACATTGTGCGAGTACATTCTATTACCTTTTTAC 
 
example G5_EXTs  
G5 TATA u213 ACATACATTTACTTACACATTCTGGGTGAACATTTACAATCAATCCTTT 
G5 TATA u214 CAAATACTACATCAAATCTATCACCGAGATCTATACTAATCATCATCTA 
G5 TATA u215 TCTAACATTACTATCACTTTAGACCCAGACTTTTTACTTACCAAATCTA 
G5 TK u102 TACTAATCCTTTCAAACTTTACACGGACACTTTACATCAAATACTAATC 
G5 TK u104 ACATTCTACAAAATCAACATAGAGGCTGTACATACATTACTATCAACAT 
G5 TK u62 CAAATCTATACTCAAAACATAGTGGGTGAACATTACTTACTATCATCTA 
G5 TATA u129 TACTACATTTACAATCTCTAAGTCCCAGATCTATCTACTTTTACTACAT 
G5 TATA u220 ATCATTACTCTATCTACTTTACTGCGTGACTTTCTTTTTACCTTTACAT 
G5 TK u93 TTACCTTTACATAATCACATTGTGCCTGAACATCTTTTTACTCTATACT 




The principle of EXTassays 
EXTassays are based on the combined use of various types of reporter gene assay 
formats to quantitatively monitor very different molecular events simultaneously 
using one decoding microarray (Figure 5). To achieve multiplexing, the standard 
reporter gene is replaced by small unique oligonucleotide reporters, termed expressed 
unique sequence tags (EXTs), whereby each unique EXT serves as a specific reporter 
for a defined cellular assay. Multiple EXT reporters expressed in one cell or cell 
population can be isolated as a pool, amplified and analyzed simultaneously by 
hybridization to a diagnostic microarray (“barcode array”). Measuring the expression 
levels of all EXT reporters in this way can principally provide quantitative data for a 
plethora of cellular assays at once. The approach can easily be applied particularly for 
a large scale measurement of cis-regulatory element activities as each cis-element is 
physically linked to a particular EXT sequence in one plasmid construct. A mixture of 
such constructs can be transfected and assayed simultaneously since there will be no 
crosstalk between the “assays” operating in one cell. Activation of certain cis-
regulatory elements will not only reveal the activity of transcription factors or 
transcription factor complexes but also indicate the activation of certain signal 
transduction pathways (Romanov, Medvedev et al. 2008). One of the advantages of 
this approach is that it provides a platform for the integration of other reporter gene 
coupled assays, i.e. for the measurement of signaling events upstream of transcription. 
For example, Split-TEV assays monitoring regulated protein-protein interactions can 
be coupled to a reporter gene readout and can thus be integrated into multiplexed 
EXTassays to measure signal transduction at different levels within one experiment 
(Wehr, Laage et al. 2006; Wehr, Reinecke et al. 2008).  
The ultimate goal is to provide a more complete view to the dynamics of the signaling 
cascade of interest. In the present setup, unambiguous coupling of each Split-TEV 
assay to a unique EXT reporter is ensured by coexpression of the assay components 
and an appropriate reporter within one cell. Therefore, separate transfections are 
performed for each protein-protein interaction assay and the cells are subsequently 




Figure 5. The principle of the EXTassay. EXTassays are based on simultaneous expression of 
multiple reporter constructs. These are invariably linking defined cellular assays to unique 
oligonucleotide sequences that can be discriminated e.g. by hybridization to a custom “decoding” 
microarray or by any other RNA profiling technique. Quantitative and simultaneous measurement of 
very different signaling events can be performed with different types of reporter gene assays. For 
example, Split-TEV assays can be combined with cis-regulatory assays to simultaneously monitor for 
receptor activation and downstream signaling at the level of activated transcription factors. 
 
For EXTassays, total RNA is extracted and cDNA is synthesized. Subsequently, 
EXTs are amplified by PCR, labeled and analyzed with microarrays. The relative 
signal intensities of the different EXTs serve as a measure of the corresponding 
cellular assays. The performance of our approach critically depends on the 
functionality of the EXT oligonucleotide reporters. Unoptimized “random” sequences 
would lead to a distortion of quantitative data due to inhomogeneous performance of 
the reporters in amplification and hybridization procedures. All EXT oligonucleotides 
should display equal melting temperatures and no high energy secondary structure to 
allow optimal microarray hybridization performance. The library should contain a 
large number of unique EXTs to allow future upscaling of the EXTassay for high 
throughput applications.  
Therefore, we have designed and synthesized a highly complex oligonucleotide 
library with the described properties. The combinatorial synthesis followed a mix-
and-divide strategy illustrated by Figure 6 (Rossner 2008). 
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Structure and properties of the EXT reporter library 
The EXT oligonucleotide library contains 5’ and 3’ invariable regions and a central 
49-mer variable region. The variable region has a symmetric organization and consists 
of 10 structural modules called “words” (W) that flank a central core region. Each 
word consists of 4 nucleotides. Out of all possible 4-nucleotide combinations only 8 
are used that are built of three adenosine (A) or thymidine (T) residues, only one 
cytosine (C) and no guanine (G) residues at all. This structure yields balanced melting 
temperature and virtually absent intra- and intermolecular complementary regions for 
each member (Brenner, Williams et al. 2000). Each of the eight possible words 
(CTTT, CAAA, ACAT, TCTA, TACT, ATCA, TTAC, and AATC) occurs randomly 
at each of the ten possible positions. According to this principle, 810 different 
combinations can be produced. The core region comprises nine bases of alternating 
A,T  (W) or G,C (S) residues with three centrals G,C (S) residues (Figure 6) (Rossner 
2008). Therefore 29 (2 bases at 9 positions) = 512 different core sequences are 
possible. The total complexity of the EXT library can be calculated as:  
810 x 29 =1 073 741 824 x 512 = 549 755 813 888  
≈ 5,5x1011 = maximal library complexity 
The 9-mer core element was introduced to allow monitoring the performance of each 
EXT with a few central mismatches and to enhance and stabilize the melting 
temperature profiles for hybridization approaches. Moreover, the core element 
increases the complexity compared to a pure word structure by approximately one 
order of magnitude. The balanced base pair composition and homogeneity of the EXT 
library was analyzed by Sven Wichert using R-scripts. A large virtual library of 
100000 (100K) EXTs and an equal size library of random 49-mer sequences were 
generated and their melting temperature (Tm) profiles were calculated. These data 
were then compared to the Tm data for 229 cloned and sequence verified EXTs. The 
virtual and cloned EXT libraries display a highly narrow Tm range with an average of 
61,2 °C and a standard deviation of 0,7 and 0,8, respectively. In contrast random 49-
mers display a much broader Tm distribution and significantly higher average melting 
temperature of 70,1 ± 3,3 °C (Figure 7a). The EXT design also yielded in a low 
cross-similarity profile within the cloned EXT library. The majority of the 229 EXT 






Figure 6. Structure and synthesis strategy of the EXT oligonucleotide library.  
 Each oligonucleotide in the library carries 5’ and 3’ short invariable regions and a 49-mer variable 
region consisting of ten 4-nucleotide units (“words”=W) and a 9-mer core sequence. The lower part of 
the figure illustrates the “mix and divide” principle of the EXT library synthesis used for random 
incorporation of the 8 possible words into 10 possible positions (a more detailed description is 




Figure 7. Melting temperature (Tm) and similarity profiles of EXT oligonucleotide libraries.  
(a) The histogram in red shows the Tm distribution for 229 cloned and sequenced EXTs. It follows the 
narrow range outlined by the calculated Tm distribution for 105 randomly computed EXT sequences. 
All EXT oligonucleotides show a very consistent and narrow range of melting temperatures compared 
to 105 computed random 49-mer sequences (dashed line). For computed libraries the frequency values 
are shown which indicate the number of sequences with particular Tm relative to the total.  
(b) Similarity profile histogram for a cloned library of 229 unique EXTs shows that the majority of 
sequences share less than 20% identity. The y-axis indicates the number of pairwise combinations with 




Optimization of the hybridization conditions 
All data on the mismatch control performance shown below are derived from 
hybridization of custom Agilent microarrays at 65°C with the supplied buffer 
supplemented with 15% formamide and blocking DNA for increased stringency. 
Hybridization of NimbleGen arrays were equally optimal at 50°C with standard 
hybridization components (data not shown).  
The cross hybridization profile of the mismatch controls is a function of hybridization 
conditions. In general, an optimal trade off between high stringency and overall signal 
intensity should be achieved. 
We have tested a range of hybridization conditions and hybridization temperatures. 
Three different microarray platforms were tested: self spotted microarrays and custom 
microarrays from Agilent and Roche/NimbleGen. NimbleGen arrays were finally 
used for the biological experiments. Hybridization of the NimbleGen arrays at 45°C 
resulted in substantially elevated levels of cross hybridization. At 60°C and 55°C the 
signal intensities were not sufficient to exploit the full range of the scanner dynamics.  
The best outcome was obtained at 50°C with high signal intensities for perfect match 
probes and adequate mismatch signal profiles. For the biological experiments later on, 
the temperature was reduced to 48°C to facilitate the resolution of lower signals. This 
has slightly increased the signals at the mismatch controls but did not affect the data 
quality since the extent of similarity between the unique EXTs used for the 
experiment is by far lower than for the mismatch controls and far beyond a critical 













EXT performance in a microarray hybridization 
Cross hybridization is one of the most important issues to be addressed when working 
with microarrays. The probes have to be selected for low similarity and the 
hybridization conditions have to be optimized to achieve high discrimination.  
We have used a broad panel of control sequences to explore the EXT properties with 
respect to cross hybridization and to monitor the stringency under given hybridization 
conditions. We randomly selected five “control” EXTs (c1-c5) for a thorough 
evaluation of their performance in microarray experiments (Figure 8). For each of 
these EXTs, a set of controls was designed by introducing various numbers of 
mismatch nucleotides at different positions within the sequence. Roughly 700 
different mismatch controls per EXT were used which makes 3500 in total. To 
introduce a mismatch without altering the melting temperature of the oligos, adenine 
(A) was always exchanged to thymidine (T) and cytosine (C) to guanine (G) and vice 
versa. The following mismatch controls were designed: (i) 1-8 bp long mismatches 
were introduced at every possible position along the “mother” sequences of c1-c5, (ii) 
different word mismatches or word mismatch combinations at different positions and 
(iii) combinations of single nucleotide mismatches in the core element with word 
mismatches. 
Among the eight possible words used in the EXT library there are always 2 words that 
share a C at the same position and 3 words that share an A or T at the same position, 
however, not more than one nucleotide is identical. While G/C nucleotide pair 
contributes three hydrogen bonds to the hybridization the two words sharing a C have 
to be considered the most similar of all. To test wether such words would be 
discriminated, a subset of mismatch controls was designed where one or more words 
 
 
Figure 8. Control EXTs c1-5. Five randomly picked oligonucleotides that were cloned from the EXT 
library and sequenced show low similarity to each other. Each of the 8 possible words is depicted in a 
different color to illustrate the diversity of word composition. These five sequences were designated 




were exchanged to its most similar word-counterpart: CTTT/CAAA, ACAT/TCTA, 
ATCA/TACT, AATC/TTAC. Up to five word mismatches were introduced at 
various positions as well as combinations of single word mismatches distributed along 
the sequence.  
Microarrays with mismatch control as well as perfect match oligonucleotides 
complementary to c1-c4 (the probes) were hybridized to the corresponding 
fluorescently labeled c1-4 products (target). Thus, we could precisely determine cross 
hybridization profiles and optimize the conditions to yield optimal hybridization 
dynamics. As expected, perfect matches displayed the highest fluorescence intensity. 
At optimized hybridization conditions mismatch sequences showed dramatically 
reduced signals depending on the position and length of the mismatch. The cross 
hybridization was estimated as a percentage of the fluorescence observed for a 
mismatch probe relative to the perfect match of the corresponding control EXT. As 
shown in Figure 9, a significant discrimination was observed already with one base 
mismatch at central positions. The discrimination was further improved as the length 
of the mismatch was increased to 2, 4, 6 or 8 nucleotides. This was, however, not the 
case for the sequences with the central region identical to that of the control EXT 
(Figure 10, Figure 11). The extent of discrimination depended to a larger extent on 
the position of the mismatch rather than on its length. Analysis of the word based 
mismatches showed that a word mismatch displays the same discrimination as a 
corresponding 4-nucleotide mismatch even though one of the four nucleotides of the 
word (always the C) was not altered (Figure 11). This means that all of the eight 
words can be discriminated equally well. One word mismatch displayed full 
discrimination when located rather centrally at position 3-7 but not at the outermost 4 
slots. These positional effects could be abolished by having at least one base 
mismatch at any position in the core sequence (Figure 12). In other words, a perfect 
discrimination could be achieved with as little as one central base and one word 
difference at any position. Without a central mismatch, 5 word mismatches were 
needed to reach full discrimination independent of the mismatch position (Figure 13). 
For oligonucleotides with mismatches only at the boundary, the minimal difference in 
sequence required for full discrimination is approximately 40% (5 words = 20bp, 
20/49=40,8%). For sequences with one or several mismatches at other positions far 
more similarity can be allowed. With the achieved hybridization specificity for the 
tested microarray platforms, the least possible complexity of the cross hybridization 
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free EXT library equals the complexity of the EXT central region without the 5 words 
at the boundary and can be calculated as:  
85 x 29 =32.768 x 512 = 16.777.216 
≈ 1.7x107  
= minimal complexity allowing full discrimination with microarrays 
So far, we have cloned and sequenced about 600 unique EXTs and have not 
encountered any problem of EXT similarity. We conclude that the EXT reporter 
library is indeed physically highly complex and provides large numbers of 
significantly different sequences. As the size of the operating EXT library grows in 
the future, however, sequences with higher similarity will be emerging which should 
not be used in the same experiment. Without considering the positional effects, a 
general cut off could be set to a minimum of 40% overall sequence difference (see 
above) or maximum 60% identity. This would be a very rigorous requirement as the 
vast majority of excluded sequences would not show any interference. Theoretically, 
computer algorithms could be developed that would allow to also consider position 
effects to increase the number of EXTs available for experiments. This will, however 
only be needed when more than 10 million assays shall be performed in parallel. 
Therefore, when compiling new EXT sets by cloning and sequence verification the 
results of the control experiments described here have to be taken into account. It is 
important to note that the hybridization dynamics of all control EXTs is highly 
similar. The signals of the mismatch probes follow the same pattern of signal intensity 







Figure 9. Cross hybridization profile for single base pair mismatch controls. Four control EXTs 
c1-4 were hybridized to a microarray harboring a perfect match and a set of mismatch sequences. 
Representative sequences for EXT c4 are shown on the right. The perfect match sequence is depicted in 
red and the position of the mismatch is highlighted in blue. Due to high sequence similarity, EXTs c1-4 
cross hybridize to the mismatch sequences. The extent of cross hybridization is plotted for each 
mismatch probe as a percentage of the perfect match signal. Average cross hybridization profile for all 
4 control EXTs is shown on the left and specific data for the c4 in the middle. Even with one base 
mismatch in the central region, the signal drops dramatically suggesting a high specificity of the 






Figure 10. Cross hybridization profile for two base pair mismatch controls. Four control EXTs c1-
4 were hybridized to a microarray harboring a perfect match and a set of mismatch sequences. 
Normalized spot intensities for EXT c4 are shown in the middle and corresponding probe sequences on 
the right. The average intensity plot of c1-c4 on the left shows highly reproducible behavior of all four 
control EXTs. All signals are normalized to the perfect match intensity. The discrimination is 
substantially improved compared to one base mismatch. The average signal in the central region 
(excluding 2 boundary words on each side) is 11±4 for 1b and 5±2 for 2b mismatch. For some central 
mismatches the signal drops to 2% of the maximal intensity close to the background level (1,65%) 






Figure 11. Comparison of the cross hybridization profiles for 4 and 8 bases versus 1 or 2 words 
mismatches at corresponding positions. Average data for c1-4 and sequences for c1 are displayed. 
Cross hybridization levels for 4 and 8 base mismatch probes are plotted in black and for 1 and 2 words 
mismatch probes in red. In contract to a 4-base mismatch, in 1 word mismatches a cytosine base is not 
altered which should be considered because words with one common nucleotide are found in the EXT 
library. The signals appear to have very similar dynamics with only slightly higher edge effects for one 
word mismatch. Which means that all words can be well discriminated. For most of the mismatch 
sequences perfect discrimination is observed. Although some edge effects remain for EXTs with only 




Figure 12.  Combining single central mismatches with single word mismatches. Oligonucleotides 
carrying at least one base mismatch in the center and at least one word mismatch at any position can be 
fully discriminated by microarray hybridization. Boundary effects for one word mismatch controls are 
abolished by only one additional base mismatch in the center. The variation depending on the central 







Figure 13.  Cross-hybridization profiles with multiple word mismatches. To attain full 
hybridization specificity for the sequences with identical core region several words differences are 
required. With more than 4 words differences, perfect discrimination is achieved independent of the 
mismatch position. Sequences with boundary word mismatches are shown because at more central 





Dynamic range of the microarray based EXT measurement 
In order to address the performance and dynamic range of the EXT microarray 
analyses, we have mimicked an EXTassay with a defined signal range by using a 
“spike in” mix of eight individually labelled unique EXTs. Two distinct EXTs were 
allotted to each of the concentrations ranging over two orders of magnitude. 31,2 fmol 
of the spike in mix (containing 0.1 fmol of the EXT13 and 14, 0,5 fmol - EXTs15/16, 
5 fmol - EXTs17/18 and 10 fmol - EXTs19/20) were hybridized to a NimbleGen 
microarray in the presence of 85 fmol of the control EXT c5. In a second experiment, 
double the amount (2x) of the spike in mix and the same amount of the c5 was 
analyzed. Two fold differences of the spike in EXT signals over a range of 
concentrations were assessed ( 
Figure 14) The concentrations were adjusted to the amount of the Cy3 dye (fmol) and 
not to the amounts of RNA, to correct for slight differences in dye incorporation rates 
from EXT to EXT. In a real experiment all EXTs would be labelled in a complex 
mixture and therefore assumed to have equal labelling efficiencies. 
All hybridized EXTs showed signals proportional to their concentrations in the mix. 
Already at 0,1 fmol, an increase in the signal intensity over the background was 
detected for EXTs 13 and 14 (178±30).  Two fold differences between the two 
hybridization mixes could be measured. The average fold difference between the 
spikes in the 1x and 2x mixes for all of the EXTs was only slightly below the 
expected two-fold difference (1,84±0,19). This slight deviation from the expected 
ratio is consistent for all eight EXTs and can, therefore, most likely be attributed to a 
pipetting error.  
The average background value of roughly 100 (110±5) was calculated from the spot 
intensities corresponding to the EXTs that were not present in the target mixture. The 
maximal signal of the particular hybridization is represented by the average c5 
intensity at around 30000 (29117±3722). The dynamic range outlined by these two 
values is about 300 and constitutes more than two orders of magnitude. As long as the 
c5 intensity does not reach the maximum of 65000 units allowed by the scanner 
sensitivity and the Cy3 dye is used that displays elevated background compared to the 
Cy5, this range could in fact be improved to roughly 600 for Cy3 dye and up to three 
orders of magnitude for Cy5. Two fold differences in the EXT abundances could be 
robustly measured at the amount of 0,5 and 1 fmol which relates to the overall amount 
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of the target as approximately 1:10 000 (8500 / 0,5 = 17000 and 8500 / 1 = 8500). 
This indicates that with respect to target concentrations in a complex EXT mixture at 
least 4 orders of magnitude can be resolved. 
In summary, the optimized microarray readout for the EXT quantification allows to 
monitor abundance differences within complex samples with high sensitivity over 





Figure 14. Assessment of the dynamic range of microarray based EXT analysis. A spike in mix of 
individually labelled unique EXTs 13-20 was prepared with individual EXT concentrations ranging 
over two orders of magnitude. 31,2 fmol of the spike in mixes (containing 2 different EXTs at the 
amount of 0,1fmol, 0,5fmol, 5fmol and 10fmol fluorescent dye) were hybridized to one microarray (1x) 
and double the amount (2x) to the second microarray. High excess (8500 fmol) of the control EXT c5 
was added to both hybridizations. The signal profiles show increasing intensities for the EXTs spiked 
in at rising concentrations (inlay depicts EXTs 8-20 at reduced scale). The dynamic range spans over 
more than two-orders of magnitude. Average background represented by the signals of EXTs 1-12 is 







Robustness against amplification biases 
Measurement of the relative abundance of the EXT reporters by microarray 
hybridization involves several amplification steps. Current protocol includes an 
exponential PCR amplification and two linear amplification steps: reverse 
transcription and in vitro transcription. It is known that due to different mechanisms 
depending on the template length, relative abundance and/or nucleotide sequence 
composition some templates tend to be unequally amplified in PCR reactions and 
most likely also in IVT reactions (Kanagawa 2003). As a result, the composition of a 
complex mixture may be biased during PCR amplification. The balanced structure 
and base pair composition of the EXTs should not only facilitate their optimal 
performance in the microarray hybridization but also make sure that the relative 
abundance of each EXT within the complex mixture stays constant during 
amplification procedures. To verify this assumption, we have performed a series of 
control experiment by comparing the relative abundance of amplified and unamplified 
EXT mixtures. Different amounts of control EXTs c1-4 were combined in the 
presence of a large access of the c5. Four mixtures were prepared, each one 
containing twice more of c1-4 than the previous one 
(MixA:MixB:MixC:MixD=1:2:4:8). Therefore, each EXT should theoretically show a 
two fold difference from mix to mix when analysed by microarrays. The exact 
compositions of the mixes are shown in Figure 15a. All mixtures were diluted 104, 
108 and 1010 fold and PCR amplified for 40 cycles. According to the dilutions, 0,1ng, 
10fg or 0,1fg were used as input. The PCR products as well as unamplified mixtures 
were labelled and analyzed by hybridization to self spotted microarrays 
(Figure15b,c). Signals in the amplified and unamplified samples show highly similar 
patterns of intensity and the two-fold differences between the mixes A-D are 
preserved after the amplification. Average correlation coefficient between all four 
data sets is 0,991±0,014. This strongly suggests that the PCR amplification does not 






Figure 15. Controlling a potential PCR amplification bias. (a) Composition of the 4 control mixes 
(A, B, C and D). The amount of input PCR products for control EXTs c1-5 is given in nanograms. (b) 
Patterns of signals produced by the control mixes hybridized to 4 separate microarrays (A, B, C and D). 
The c5 signal is not shown for better visualization of lower signals. (c) Control mixes (A-D) were 
highly diluted, PCR amplified and analyzed by microarray hybridization. Dilution factors are shown in 
the corner of each graph. The pattern of signals is not altered after PCR amplification and is 
independent of the dilution factor which indicates homogenous and reproducible amplification. 
 
In summary, the set of control experiments above has revealed that: 
 
(i) the hybridization dynamics of c1-4 are highly similar 
(ii) even very similar sequence-related EXTs can be discriminated with high specificity 
(iii) abundance differences can reliably be determined at very low input concentrations  
(iv) amplification of EXT template mixtures with PCR does not cause any detectable bias in 
the sample over ten orders of magnitude. 
 
We conclude that EXTs are optimally suited targets for microarray analyses and 




Design and analysis of EXT reporter constructs 
The invariable regions of the EXT were introduced to serve as primer binding sites for 
amplification and subcloning purposes (Figure 6). The EXT library was amplified 
with primers carrying long overhang regions to attach sequences important for the 
functionality of the EXT reporter oligonucleotides in the experimental workflow 
(Figure 16). The outermost sequence stretches contained specific recombination sites 
for efficient cloning of resulting PCR products. Additionally, for the amplification of 
expressed EXT pools after reverse transcription, two primer binding sites designated 
as “Decoder primers” (Dec1 and Dec2) were introduced. And finally, bacteriophage 
T7 and T3 promoter sequences were placed adjacent to the EXT variable region to 
enable in vitro transcription from preferred strands to generate target RNAs for 
microarray hybridizations. To generate large numbers of EXT-reporter constructs, we 
used a multi-component modular recombination cloning strategy (“Multisite 
Gateway”) (Figure 16). Initially, a shuttle clone library was created carrying 
approximately 105 full length EXTs. About 500 single clones were isolated and 
sequenced. In parallel, thirty cis-regulatory elements (Table 1) and two minimal 
promoters: TATA-box and herpes simplex virus thymidine kinase promoter (TK) 
were cloned into similar shuttle clone vectors. Most of the cis-elements were 
amplified along with the minimal promoters “TATA”-box or TATA-like promoter 
(TAL). For cis-reporters, no additional minimal promoter was used and the constructs 
were 5’ supplemented with a strong transcriptional pause site (Figure 17). Final 
reporter constructs were generated by single recombination reactions of several 
selected shuttle clones into a firefly luciferase reporter vector backbone. In the final 
assembly, a cis-element, a minimal promoter and an EXT were placed upstream of the 
firefly Luciferase reporter gene such that upon cis-element activation, an EXT and the 
firefly luciferase are expressed on the same mRNA. Therefore the same constructs 
could be used to conduct multiplexed EXTassay and single luciferase reporter 
measurements to compare the two techniques and asses the reliability of the 
EXTassay approach. Three unique EXTs were assigned to each cis-element, to 
generate three distinct EXT reporter constructs of which at least two were 
successfully cloned and used in the experiments. The list of EXT reporters used in his 






Figure 16. EXT amplification and subcloning strategy. The EXT oligonucleotide library was PCR 
amplified and subcloned to generate a library of shuttle clones.  Several functional elements were 
introduced flanking the EXT sequence: recombination sites (R-Site1/2), “decoder” primer binding sites 
(DEC1/2) and viral promoters (T3/T7). Three shuttle clones harbouring different functional elements 
were used in one recombination reaction to place a cis-regulatory element, a minimal promoter and an 
EXT in front of the firefly luciferase reporter gene (Rep). Depending on the shuttle clone, defined cis-
regulatory elements were linked to unique EXTs. 
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Table 1. List of cis-regulatory elements  
Cis-element Transcription factor Pathway 
MEF-1 MYOD-1  
MEF-3 Six1-6 homeoproteins Muscle differentiation 
ELK1 ELK-1 Ras/Raf/MAPK 
EGR3 EGR3  MAPK 
NFAT NFAT PKC & Ca2+/calcineurin 
GATA Globin TF family (GATA1-6) BMP/ Calcineurin 
HRE HIF-1 Hypoxia 
IRF-1 IRF-1 JAK/STAT 
Stat3 STAT3/STAT3 JAK/STAT 
GAS STAT1/STAT1 JAK/STAT 
ISRE STAT1/STAT2 JAK/STAT 
E2F E2F family cell cycle 
Myc Myc Wnt, Shh, EGF, MAPK 
p53 p53 cell cycle/apoptosis 
Rb Retinoblastoma protein cell cycle 
AP1 AP-1 (c-jun/c-fos) SAPK/JNK /MAPK 
CRE CREB JNK/p38 & PKA 
GRE Glucocorticoid Receptor Glucocorticoides 
HSE HSF heat shock response 
SRE Elk-1/SRF (TCF) MAPK/JNK 
NFkB NFκB NFκB/IKK 
E-box bHLH proteins Metabolic and circadian control 
PR Progesteron Receptor Progesteron 
ER Estrogen Receptor Estrogen 
AR Androgen Receptor Androgens 
RxR Retinoic X Receptor Retinoic Acid 
RxR2 Retinoic X Receptor Retinoic Acid 
RAR Retinoic Acid Receptor Retinoic Acid 
G5 Gal4-VP16 (GV) artificial transcription factor 
 
A separate library of EXT reporters was cloned under the control of the “G5” cis-
element (5 clustered Gal4 binding sites) that can be activated in mammalian cells by 
the synthetic transcriptional transcription factor GV (a fusion of the yeast Gal4 DNA 
binding moiety and the strong transactivator domain derived from the Herpes Simplex 
Virus protein VP16). These constructs provide a proven reporter system that is 
independent of endogenous factors in mammalian cells and, therefore, well suited for 
studying the performance of the EXTassay with precisely controlled levels of GV. 
Moreover, the Split-TEV system relies on the nuclear translocation of the GV 
transcription factor to link the protease reconstitution assay to a transcriptional 




Figure 17.  EXT reporter constructs. (a) Standard and modular reporter constructs with two different 
minimal promoters (TATA-box and TK promoter). “pause” stands for a transcriptional pause site and 
G5 for the five times Gal4 binding site. B1,B2,B3 and B4 designate recombination sites. (b) Functional 
test of the EXT reporter constructs by the Luciferase reporter gene assay.  Three constructs depicted 
above were transfected into PC12 tetOFF cells with or without GV (Gal4-VP16 transcriptional 
activator). TATA-box EXT construct shows similar activation levels compared to the standard 
Luciferase reporter plasmid while the TK_EXT construct shows significantly higher signals in response 
to cotransfection of the GV. The inlay image shows the elevated background activity of the TK 
minimal promoter in comparison to the TATA-box. 
 
constructs with both, TATA and TK minimal promoters (Figure 17a) was assessed 
by the luciferase reporter gene assay and compared to the performance of the standard 
G5-reporter carrying a TATA-box. Experiments with several modular EXT reporter 
plasmids have revealed that TATA-box carrying constructs perform as efficiently as 
the standard G5-luciferase reporter construct. They show equal background levels and 
similar induction rates upon cotransfection with GV. As expected, the stronger basal 
activity of the TK promoter displayed elevated levels of constitutive reporter 
expression and correspondingly higher maximal activation levels in PC-12 cells 
(Figure 17). The average induction rate (the maximal signal divided by the 
background) is similar for the TK promoter and for the TATA-box and lies between 
100 and 1000 fold depending on the cell type and the time line of the experiment. 
Therefore both TK and TATA-box containing modular constructs provide a good 
measurement window for transcriptional activation. 
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Comparison of the ”RNA” and luciferase reporter 
We have performed a pilot experiment to get a first performance estimation of an 
RNA-based assay compared to a protein-based reporter gene assay. In the present 
design of the EXTassay reporter constructs, the EXT is expressed on the same mRNA 
as the firefly luciferase open reading frame. Considering the synthetic nature and the 
small size of the EXT, we assumed that the mRNA stability should be similar to the 
stability of the firefly luciferase mRNA alone. To assess the protein and mRNA 
stability, we used the tet-Off reporter system that allows the immediate shutting down 
of the reporter gene expression upon addition of doxycyclin to the medium (Gossen 
and Bujard 2002). The assay was performed in PC-12 tet-OFF cells stably transfected 
with the tTA transcriptional activator that binds to the tetracycline operator sequence 
(tetO) and drives constitutive expression of the reporter gene. Doxycyclin (Dox) 
sequesters the tTA protein, prevents it from binding to the DNA and inhibits 
transcription of the tetO reporter construct (Figure 18a). The cells transfected with 
the tetO controlled Luciferase reporter plasmid (pUHC13-3) were allowed to express 
the firefly Luciferase for 12 hours. The transcription was inhibited by adding Dox 
(500 ng/ml) and samples were collected at different time points. The abundance of the 
reporter protein was quantified as the Luciferase activity and the mRNA abundance 
by quantitative PCR relative to beta-actin mRNA. Control populations of cells 
received Dox simultaneously with the transfection and were used to determine the 
background expression levels of the reporter. Luciferase activity reached background 
levels after 48 hours (estimated half life ~6h) due to high stability of the firefly 
Luciferase protein (Figure 18b). In contrary, the Luciferase mRNA is depleted to 
background levels already at 8 hours after transcription has been shut down (estimated 
half life <2h) (Figure 18c). The tetO-luciferase construct used in this experiment 
carries an early simian virus 40 polyadenylation signal whereas the EXT reporter 
constructs embedded in the pGL3 reporter vector backbone are linked to the late 
SV40 polyA. This difference as well as the presence of the EXT might influence the 
RNA stability. The actual RNA stability for the modular EXT reporter constructs 
remains to be quantified but from this analysis it clear that RNA reporter provide 




Figure 18.  Stability of the Protein-based versus mRNA-based reporter. (a) PC-12 tetOFF cells 
were transfected with the tetO_CMV_Luciferase reporter constructs carrying the CMV promoter and 
the tetracycline responsive cis-element (tetO) that is activated by the tTA transcription factor. After 12 
hours of Luciferase expression, the activity of tTA was inhibited by addition of Doxycyclin and the 
transcription was blocked. A control sample was exposed to doxycyclin from the beginning of the 
experiment to indicate the background level of the system. After transcription has ceased, the stability 
of Luciferase mRNA and protein was determined by taking samples at various time points. (b) The 
activity of the Luciferase persists for many hours and reaches the background at 48 hours after 
Doxycyclin addition. (c) The mRNA abundance of the Luciferase relative to b-actin mRNA declines to 
background levels already after 8 hours. 
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Multiplexed EXT analysis with microarrays 
The first multiplexed EXTassay measurement with microarrays was performed in a 
model experiment using G5-TK-EXT-Luciferase reporter constructs. Transcriptional 
activation of the reporters was controlled by coexpression of GV under the control of 
the CMV promoter. To explore the sensitivity of the system, the dynamic signal was 
simulated by using different amounts of GV-encoding plasmid DNA from sample to 
sample. The experiment was controlled in parallel by the Luciferase activity 
measurement.  
Because high numbers of “unregulated” signals are required for proper microarray 
normalization, we have allotted a large subset of EXT reporters (EXT11-70) as a 
“reference EXT pool” and a smaller number (EXT1-10) as the “assay pool” that served 
for the measurement of the dynamic signals. In total, 80 different EXT reporters were 
used in the analysis. The experiment was done in PC12 tet-OFF cells and five 
separate transfections were performed. Four subpopulations of cells received the 10 
assay EXTs and corresponding increasing amounts of GV: 0ng, 0,1ng, 1ng or 10ng, 
respectively. The fifth and larger subpopulation of cells was transfected with the 60 
EXT plasmids of the reference pool and a constant amount of GV. The DNA amount 
in the reference pool transfection was adjusted to elicit reasonably high and robust 
expression in the range of the expected assay pool signals. Several hours after 
transfection the cells from the assay pools were mixed with equal amounts of the 
reference pool, plated out and cultured under identical experimental conditions 
(Figure 19a). In this way, the reference pool EXTs were always processed together 
with the assay EXTs and could serve as an internal control for the expression, 
amplification and handling procedures.  
The RNA and DNA were extracted from the cells 48 hours after transfection (Figure 
19a). The RNA samples containing expressed EXT reporters served for the actual 
assay readout, whereas the DNA samples reflected the composition of the input 
plasmid DNA that was successfully transfected into the cells and actually contributed 
to the assay. We used the DNA input samples as an additional internal normalization 
control correcting for the pipetting or DNA concentration measurement errors and 
possible inhomogeneity in the transfection efficiency. For the RNA samples, the 
cDNA was prepared using random nanomer primers and the EXT reporters from both 





Figure 19. Testing EXTassay performance under control conditions. (a) The experimental design 
of the GV/G5 controlled multiplexed EXTassay. Increasing amounts of GV cotransfected with the set 
of G5-TK-EXT1-10-Luciferase reporter plasmids (“assay EXT pool”) simulate a dynamic cellular 
signal. Equal number of cells transfected with the “reference EXT pool” (G5-TK-EXT11-80-Luciferase) 
and a moderately high amount of GV are plated with each of the assay cell populations and serve as an 
internal control. After 48h at 37°C, RNA and DNA were isolated from all samples. The RNA was 
reverse transcribed into cDNA containing expressed EXT reporters and the DNA contained EXT 
encoding plasmids that entered the cells during transfection. The EXTs from both cDNA and plasmid 
DNA input were PCR amplified labeled with Cy5 and Cy3 dyes, respectively, and hybridized to a 
separate microarray for each of the 4 conditions. (b) Analysis of corresponding EXT PCR products 
obtained from cDNA samples with Dec1/Dec2 primers at 30 cycles. The negative control indicates that 




PCR amplified for 30 cycles with the Dec1/Dec2 primer pair (Figure 19b). The PCR 
with the corresponding RNA samples controls for the possible plasmid DNA 
contamination in the RNA preparation. The 153 bp long PCR products were further 
used for in vitro transcription from T7 promoter to generate the 111b long RNA target 
for the microarray hybridization. The workflow of the EXT amplification is described 
in detail in materials and methods and illustrated in the Figure 21. DNA derived 
samples were labeled with Cy3 fluorescent dyes and the RNA-cDNA derived samples 
with Cy5. Each of the four samples that were transfected with the different GV 
amount was subsequently hybridized to a separate diagnostic microarray. Control 
EXTs c1-c5 were used in each hybridization for monitoring of the hybridization 
stringency. The cDNA derived fluorescent signals in the Cy5 channel were 
normalized to the plasmid DNA input signals in Cy3. The normalized signal 
intensities of the EXTs 1-10 increased in a dose-dependent manner with highly 
similar slopes (Figure 20a). In contrast, the signal intensities of EXTs 11-30 (derived 
from the reference EXT pool and exposed to a constant amount of GV) remained 
highly similar between the arrays (Figure 20b). The EXTs 71-90 that were not 
present in the transfection reflect overall microarray background and show virtually 
no signals which also indicates the specificity of hybridization (Figure 20c). The dose 
response curve of the microarray measurement (Figure 20d) appears very consistent 
with the supporting data from the luciferase reporter gene assay performed on the 
same samples (Figure 20e) The luciferase readings are derived from the EXT1-10 
transfected cells that were isolated from the assay pool before the reference pool was 
added and plated onto 96-well plates with several replicate wells for each GV 
concentration. The microarray and the luciferase signals show very similar slopes, 
however, the Luciferase assay shows higher dynamic range (40-fold maximal 
induction vs. 8 fold for the microarray) which is likely due to the stability of the 
luciferase protein and enzymatic amplification of the signal. 
 
From this analysis, we concluded that multiplexing reporter gene assays with a high 








Figure 20. Analysis of the “GV” control EXTassay. Figures (a-c) show average spot intensities for 
single EXTs from four separate microarrays corresponding to different concentrations of GV (0ng, 
0,1ng, 1ng and 10 ng). (a) Ten EXT reporters from the “assay pool” (EXT1-10) were exposed to 
increasing amounts of GV and demonstrate a clear dose-dependent increase in signal intensity. 
Although different EXTs have intrinsic performance differences the slopes of the induction are very 
similar. (b) EXTs 11-30 represent the reference pool that was subjected to the constant amount of GV. 
Therefore, each of these EXTs shows highly similar signals across all 4 arrays. Different EXTs show 
similar signals with slight variation due to individual performance differences. (c) EXTs 71-90 reflect 
the background of the hybridization. (d, e) Dose-response curves measured by microarray 
hybridizations or luciferase reporter gene assays using cells from identical transfections. Figure (e) 
shows the pooled Luciferase activity of ten reporter constructs (G5-TK-EXT1-10-Luciferase) and the 
assays’ background level. Figure (d) shows average microarray signal intensities for al the EXTs of the 
assay pool (1-10), the reference pool (11-70) and the background (71-140). Firefly luciferase and 
microarray measurements display very similar response curves although the dynamic range of the 





Figure 21. Experimental steps of the EXT analysis from transfections to microarray 
hybridization. The EXT mRNA is isolated from transfected cell populations, reverse transcribed and 
amplified by PCR. To generate single stranded target for microarray hybridization, in vitro 
transcription (IVT) is performed in the presence of aminoallyl-modified UTP. The RNA is then labeled 
by coupling of the cyanine dye esters (Cy3 or Cy5) to the aminoallyl moieties and the labeled product 




Monitoring of ErbB receptor activation                                        
and downstream signaling 
We have applied the EXTassay approach to measure the activation of the ErbB 
receptor signaling pathway in response to Nrg1 (neuregulin 1). To demonstrate the 
versatility of the EXTassay, we decided to use the recently published split-TEV 
system to monitor selected protein-protein interactions involved in the initial steps of 
the ErbB signaling and combine it with the analysis of multiple cis-regulatory 
elements at the a more distant signaling level. We have used our library of 90 cis-
regulatory EXT reporter constructs for the analysis of 30 different cis-regulatory 
elements (Table 1) with three unique EXTs each. We have measured ligand induced 
receptor dimerization and phosphorylation dependent recruitment of the downstream 
signaling proteins: SHC, Grb-2 and PI3Kp85α (Wehr, Laage et al. 2006; Wehr, 
Reinecke et al. 2008). The design of the split-TEV assays is illustrated in Figure 22. 
Upon interaction, restored TEV protease activity leads to release of the Gal4-VP16 
(GV) transcription factor. 
 
 
Figure 22. Split-TEV assays integrated into the analysis of the ErbB signaling pathway with 
EXTassays. For each receptor pair, four protein-protein interaction (PPI) assays were performed in 
parallel to the analysis of 30 cis-regulatory elements. An example is shown for the ErbB2/3 receptor 
pair (ErbB2/2 and ErbB2/4 were analyzed in the same way). The ErbB2 receptor fusion construct 
(ErbB2-N-TEV-GV) carries the N-terminal fragment of the TEV protease fused to the transcription 
factor (GV) via a TEV specific cleavage site (tevS). The other interaction partner carries the C-terminal 
fragment of the TEV protease. Upon interaction, restored protease activity leads to the release of the 




We used the GV-responsive G5_EXT_Luciferase reporter library to monitor the Split-
TEV assays incorporated into the EXTassay format. Eight unique EXTs were 
assigned to each interaction. At the same time, single Luciferase activity 
measurements were performed from the same transfections and compared to the 
EXTassay data. The constructs encoding assay components for each protein-protein 
interaction were combined in a separate transfection with 8 unique EXT reporters 
carrying either TATA-box or TK promoter. 
Out of four ErbB receptors only ErbB3 and ErbB4 can bind neuregulin. ErbB2 is 
deficient in ligand binding but acts as the preferred coreceptor for other ErbB proteins 
(Graus-Porta, Beerli et al. 1997). Therefore, we analysed two receptor heterodimers: 
ErbB2/ErbB3 and ErbB2/ErbB4, plus the ErbB2/ErbB2 homodimer and the control 
condition without any receptors (-/-).  
For each receptor combination, five separate transfections were performed: one with 
90 cis-element reporter constructs and four with corresponding split-TEV assays to 
ensure unambiguous coupling of EXT reporters. Four hours after transfection, the 
cells were mixed and plated out. We allowed 24 hours for expression of the receptors 
and subsequently stimulated the cells with soluble Nrg1 (Figure 24a) (NrgI-β1a 
isoform EGF domain, courtesy of Dr. Tobias Fischer). We harvested the cells 2h, 4h, 
12h and 36h after stimulation for luciferase assays and EXTassays. First, we 
monitored ErbB receptor dimerization and adapter recruitment by standard luciferase-
coupled Split-TEV assays. Only ligand binding competent ErbB receptor complexes 
ErbB2/ErbB3 and ErbB2/ErbB4 responded to Nrg1 stimulation, detectable after 36 
hours (Figure 23) in accordance with the literature and previous split-TEV 
experiments (Wehr et al., 2006 and 2008). In contrast, ErbB2/ErbB2 homodimers did 
not mediate Nrg1 effects but displayed elevated constitutive levels of dimerization 
over the negative control, in agreement with the previous results and the literature 
(Figure 23b). ErbB2 is known to elicit signaling upon overexpression in the absence 









Figure 23. Luciferase measuremets of the Split-TEV assays to monitor ErbB receptor 
interactions. (a) Schematic representation of the split-TEV assays for ErbB receptor activation 
measurements. Corresponding Luciferase data are shown below (b). (c) Schematic representation of the 
Split-TEV assays for the recruitment of the PI3K p85α to the phosphorylated receptor dimer. The 
luciferase activity measurements are shown below (d). Corresponding recruitment assays for SHC and 
Grb-2 are depicted in (e) and (f). Signals visible at the (-/-) condition originate from the background 
activity of the TK promoter. Elevated signals displayed by the ErbB2/ErbB2 homodimer reflect ligand 
independent ErbB2 signaling triggered by overexpression. ErbB3 and ErbB4 receptors exhibit 
maximum 2-3 fold induction in receptor dimerization in response to Nrg1 stimulation expected for 
soluble Nrg1. The induction is not apparent at earlier time points (2h, 4h and 12h) as this time is 
probably too short for detectable Luciferase expression levels.  
 
Next, we isolated plasmid DNA and RNA from the Nrg1 treated samples for 
microarray analysis as described for the previous experiment (see Figure 19a). A 
reference pool of 60 unique EXTs was added to each sample in roughly 5 fold excess 
before PCR amplification to ensure proper microarray normalization and balanced 
PCR amplification. Signals produced by expressed EXT reporters were normalized to 
the DNA input and to the average signal of the reference EXT pool. Correspondingly 
normalized EXT-reporter signals were plotted for the four time points (2h, 4h, 12h 
and 36h) and the four receptor conditions (no receptor (-/-), ErbB2/ErbB2 (2/2), 
ErbB2/ErbB3 (2/3) and ErbB2/ErbB4 (2/4)) (Figure 24). Note, that for clarity reasons 
not all individual cis-assays are plotted.  
Already 2h after Nrg1 stimulation, we observed marked changes in the assay profiles 
dependent on the different ErbB receptor combinations (Figure 24). Most 
prominently, 2/2 and 2/4, but not 2/3, significantly suppressed “AP-1” cis-reporter 
activities 2-3 fold (2/2: p<0,005; 2/4: p<0,01). Receptor combinations 2/2, 2/4 and to 
a lesser extend 2/3 also reduced “p53” mediated transcription more than 3-fold (2/2: 
p<0,005; 2/3: p<0,05; 2/4: p<0,01). In contrast, “SRE” reporter activity was elevated 
4-fold by 2/3 (p>0.005) whereas 2/2 and 2/4 had no effect at this time point.  
At 4h, the overall reporter pattern remained highly similar compared to the 2h sample. 
Nonetheless, the “AP1” cis-reporter showed a tendency of activation in the ErbB 2/3 
sample (p=0,07 versus -/- at 4h, and p=0,09 versus 2/3 at 2h) 
The highest overall activity of the Nrg1 signaling was detected at 12 hours after 
stimulation and the pattern was considerably altered compared to the 2 and 4 hours 
time points. The pattern of the cis-element activation was characterized by the 








Figure 24. Kinetic measurement of the Nrg1/ErbB receptor signaling with EXTassays. 
(a) PC-12 cells were transfected in solution with different assay components and cultured under 
identical experimental conditions for 24h to allow receptor expression. The cells were exposed to 
soluble Nrg1 and the measurements were performed at 2, 4, 12 and 36 hours after stimulation. Signals 
corresponding to different protein-protein interaction and cis-element assays are plotted along the X-
axis. For each assay, average microarray intensities of several EXT reporters are shown. Measurements 
performed at different time points are plotted along the Z-axis. Figure (b) reflects endogenous signaling 
in PC-12 cells in the absence of ErbB receptors, (c) the overexpression of the Nrg1 independent ErbB2 
protein. The results for Nrg1 induced signaling mediated by the ErbB2/3 and ErbB2/4 receptor 
complexes are shown in figures (d) and (e), respectively.  
 
The activation patterns of the 2/3 and 2/4 receptor complexes were very similar at 12h 
after stimulation although marked differences with several cis-assays were detected. 
Most prominently, differential effects were observed for “CRE” and “NFkB” 
reporters that were elevated selectively in 2/3 but not in 2/4 or the control samples -/- 
and 2/2 (CRE: p<0,005; NFkB: p>0,0005). Therefore, receptor specific signaling 
mechanisms take place in PC-12 cells and can be detected with EXTassays. 
Differences between the Nrg1 binding competent ErbB complexes 2/3 and 2/4 
became even more pronounced 36h after Nrg1 stimulation with ErbB2/3 receptor 
pairs being more effective both at the level of receptor activation and downstream 
signaling compared to ErbB2/4. 
At 36 hours after stimulation (which corresponds to 60h post transfection) overall 
signal intensity declined probably due to signaling downregulation and possibly to the 
bias related to the transient transfection conditions. Reduction in signal intensities was 
observed also in the control samples -/- and 2/2, suggesting that this is independent of 
neuregulin. Nonetheless, ErbB 2/3 protein interaction assays and some cis-assays 
continue to show high signals indicating high potency particularly of this signaling 
complex.  
Split-TEV assays monitoring dimerization and adapter recruitment revealed a strong 
Nrg1-dependent activation of ErbB2/3 and 2/4 receptor complexes. In contrast to the 
luciferase assay, ErbB protein-protein interactions could be clearly detected already at 
12 hours demonstrating the advantage of the RNA based EXT reporter system over 
the protein based Luciferase reporter (Figure 23, 24). RNA based reporter allows 
faster measurement kinetics because protein synthesis and folding steps are omitted.  
Due to their lower basal activity, the TATA-box carrying EXT reporters showed 
better induction levels compared to the TK promoter driven EXTs. Nrg1 dependent 
ErbB2/3 and 2/4 receptor activation was robustly detected at the level of dimerization 
and recruitment of the PI3K p85α subunit at 12h but not for SHC1 and Grb2. 
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Improved design of the EXT reporter constructs 
In the course of experiments, we encountered a problem of DNA contamination in the 
RNA samples. None of the present RNA purification methods guarantees complete 
removal of genomic and especially plasmid DNA. For EXTassays, it is crucial to 
obtain DNA free samples. Carry over of plasmid DNA may influence the composition 
of complex EXT pools amplified by PCR and contribute to the background of the 
measurement. So far, we have solved the problem by careful monitoring the PCR 
amplification and avoiding high cycle numbers. To achieve optimal results without a 
risk of contaminating plasmid DNA, EXT reporter constructs were modified to carry 
an intron sequence adjacent to the EXT between the Dec1 and Dec2 primer binding 
sites. Intron containing plasmid DNA templates produced a long PCR product (800 
bp) including both the EXT and the intron. On the other hand, after EXT expression 
the intron was removed by splicing and amplification on the cDNA template resulted 
in shorter PCR products of 150-200bp (Figure 25a) Based on the size difference, 
unambiguous separation of the plasmid DNA and cDNA derived PCR product are 
possible. We have generated a test construct carrying the rabbit beta globin intron 
(700 bp in size) between the TATA-box and the EXT. In front of the intron, a sense 
primer binding site (S1) was placed to serve for EXT amplification instead of the 
Dec1. PCR amplification on the plasmid DNA and cDNA template with S1/Dec2 
primer pair has revealed that the intron was efficiently spliced after expression of the 
construct in PC-12 cells giving rise to appropriate 225bp PCR product instead of 
793bp for the plasmid DNA template (Figure 25b). Even if both plasmid and cDNA 
templates were present in the PCR reaction, an amplification of the longer product 
was suppressed by competition with the more efficiently amplified short one. Hence, 
no physical separation of the two PCR products by gel extraction or other additional 










Figure 25. Improved design for EXT reporter constructs to exclude plasmid DNA 
contaminations. Trace amounts of plasmid DNA present in RNA preparations may contribute to the 
EXT amplification with Dec1/Dec2 primers producing a PCR product undistinguishable from that 
produced by the cDNA templates (a, b). PCR on a plasmid template carrying an intron sequence 
adjacent to the EXT generates a longer PCR products (800bp), whereas the cDNA derived PCR 
product is much shorter (225bp) due to the splicing of the intron (a, c). When both templates are 
present in the PCR reaction (sample2), the amplification of the longer product is suppressed with 5s as 
well as 30s extension times (c). In the case of the intron construct, the EXTs were amplified with 
S1/Dec2 primers for 30 cycles.  Thus, the insertion of an intron sequence adjacent to the EXT allows 












EXTassay readout characteristics 
The probe design for gene expression analysis with microarray is substantially 
hindered by the limited choice of sequences that are available for particular targets. 
This gives rise to potential cross hybridization problems and imperfect fitting of 
hybridization temperatures of all probes. Synthetic “barcoding” DNA sequences as 
probes that were used in several recent studies still suffer, however to a lesser extent, 
from the same problems (Silva, Marran et al. 2008). As shown here by the series of 
control experiments, the synthetic EXT sequences employed by us behave in a highly 
predictable way avoiding any cross hybridization problems. In addition, an extensive 
panel of mismatch sequences allows an integrated and rigorous control over the 
hybridization quality of each array under investigation. Moreover, the issue of 
amplification induced bias has often not been addressed thoroughly before. Due to the 
homogeneous design of the short EXTs, amplification biases are excluded from our 
approach, as judged by strict control experiments. So far, barcoding strategies are 
mostly used in yeast for tracking of the mutant strains and in RNAi screens to 
determine cell survival but not to assay individual cellular components (Giaever, Chu 
et al. 2002; Silva, Marran et al. 2008). It seems unlikely that the “unoptimized” 
barcodes used in these formats may allow similarly precise quantitative (rather than 
qualitative) cellular assays comparable to the EXTassays presented in this work. 
Nonetheless, we observed in EXTassays that EXT performed with a certain 
variability. The majority of the EXT reporters performed in the same range with slight 
variations although some “outliers” were detected. The variability of the EXT 
performance may originate from a variance in the expression level and/or 
measurement errors in the determination of plasmid DNA. We can, however, not 
formally exclude that the observed “outlier signals” may be attributed to principal 
EXT performance differences. Therefore, EXTassays in the current setup should be 
exclusively designed as comparative studies comparing identical EXTs with each 





EXTassay and standard reporter gene assays 
In its basic principle, EXTassay is a multiplexed reporter gene assay format and is not 
devoid of all the limitations associated with it. It is an indirect measurement system 
that relies on the cellular transcriptional machinery and can be influenced by general 
changes in transcription, pre-mRNA processing or RNA degradation. Each assay 
involves genetic modification of the cells with one or several DNA constructs. For 
more sophisticated assays, e.g. including protein-protein interactions, transient 
overexpression of modified proteins was employed. This caveat could be improved in 
the future by using other transfer systems (e.g. viral vectors) or by generating stable 
cell lines or batches. In most cellular assay formats (including EXTassays) proteins 
are tagged and their function might be influenced by the fused components. As a 
consequence, key findings with EXTassays should be independently verified. Another 
limitation is that EXTassay is not capable of providing fast “online” kinetic data 
compared to those obtained e.g. by fluorescence resonance energy transfer (FRET). 
Nevertheless, it allows following kinetic changes in the range of a few hours. The 
kinetic delay of the RNA based EXTassay measurement is already substantially 
reduced in comparison with the standard luciferase based reporter gene assays. EXT 
reporters do not require time for protein translation and folding and can not be 
influenced by mechanisms of translation regulation. Another kinetic advantage of the 
EXT over the firefly luciferase reporter concerns the signal persistence and the 
possibility to measure deactivation. Once expressed, luciferase protein is stable in the 
cell with a half life of app. 6h whereas the estimated half life of the EXT reporter 
mRNA is below 2 hours (Figure 18). Probably due to their ability to amplify signals, 
enzymatic reporter gene assays have been shown to be less reliable in quantitative 
measurements compared to RNA based techniques in the context of GPCR signaling 
(Kovacs and Kaplan 1992). For example, partial and full agonists might elicit equal 
luciferase reporter activities in GPCR activation assays (Kemp, George et al. 1999). 
Therefore, RNA-based reporters might be better suited for a quantitative monitoring 
of transient events involved in cellular signaling. The RNA stability may be further 
adjusted e.g. by introducing RNA destabilizing elements into the EXT reporter 
constructs. 
The dynamic range of EXTassays is largely dependent on its readout system. 
Microarray hybridization provides a maximal signal range of three to five orders of 
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magnitude disregarding the background of the experiment related e.g. to promoter 
leakiness (depending on the platform). The realistic robust dynamic range of the 
microarray based EXTassay is, therefore 2 to 3 orders of magnitude. The dynamic 
range of the luciferase measurement can be much higher, as observed in the GV 
titration experiment with GV-mediated activation of the G5_TK_EXT_Luciferase 
reporters. However, this experiment involved rather high amounts of the potent 
synthetic transcription factor (Gal4-VP16), a situation hardly encountered in the 
context of real measurements. Quite the opposite, in the ErbB receptor activation 
experiment the Split-TEV luciferase measurement shows lower induction than 
corresponding EXT reporters. The measurement of the GV-titration was performed 48 
hours after transfection when the RNA levels might have already declined while the 
ErbB activation was measured much earlier (at 2, 4, 12 and 36 hours). The kinetic 
advantage of the EXT reporter is also illustrated by the fact that the Nrg1 induced 
ErbB receptor dimerization was detected by the luciferase assay at 36 hours after 
stimulation but not at 12 hours (Figure 23). In contrast the EXT reporters showed 
maximal activation at 12 hour time point and were already reduced at 36 hours 
(Figure 24). In the future microarray hybridization might be replaced by high 
throughput RNA sequencing approaches for identification and quantification of the 
EXT reporters. The dynamic range of such readouts will certainly more accurately 
reflect real numbers. 
  
The relevance and scalability of the EXTassay  
With roughly 25000 protein encoding genes in the human genome and an average 2,5 
splice variants per gene, the proteome size is estimated to be at least ~65000. The 
number of potential pairwise interactions formed by such a network is more than 
2x109. Another level of complexity is added by the posttranslational modifications 
that are known to significantly alter the protein functions and their interactions (Papin, 
Hunter et al. 2005).  
Challenged by these numbers new technologies are moving towards development of 
highly multiplexed approaches. It is not likely that comprehensive analysis of the 
himan proteome would be possible in the nearest future but it is important to create a 
foundation for further development of such techniques. Subsets of the proteome or 
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smaller networks could be analyzed already using the available technologies. For 
example, the number of transcription factors encoded in the human genome is 
estimated to ~1850 with 2x106 possible pairwise interactions (Papin, Hunter et al. 
2005). Thus, the high number of unique EXT reporters that can be integrated in our 
system might be required if “systems-level” approaches may be addressed in the 
future.  
In the proof of principle experiment we have used roughly 200 unique EXT reporter 
sequences quantified simultaneously by microarray hybridization. The maximal 
complexity of the EXT oligonucleotide library is 5,5x1011. After extensive control 
experiments, we have shown that the minimal number of non-interfering EXT 
sequences that can be discriminated by microarray hybridization is at least 2x107. The 
realistic number is definitely higher and should be determined with additional 
computational analysis. Therefore, the current design of the EXT reporter library 
allows simultaneous measurement of at least 107 (10 million) different cellular assays. 
The complexity of the measurement depends not only on the availability of the EXT 
reporters but also on the feasibility of the measurement by a microarray hybridization. 
The capacity of the modern microarray platforms reaches 125 000 probes per subarray 
in a 12-plex format for Nimblegen and 500 000 probes per subarray in a 96-plex 
format for the Affymetrix platform. The evaluation of the assays by using next 
generation sequencing principally provides even higher throughputs. 
 
 
Flexibility of the EXTassay 
The major advantage of the EXTassay is the flexibility with which measurements of 
very different cellular events are possible within one technically rather simple 
experiment. Any assay that can be linked to a transcriptional readout can be used in 
the frame of EXTassays. The list of such assays includes standard reporter gene 
assays formats such as cis-regulatory element activity measurement, transcription 
factor activation and protein/DNA binding covered by one-hybrid assays (Deplancke, 
Dupuy et al. 2004). The range of amenable assays continues with all types of 
transcriptionally coupled protein complementation systems such as two hybrid assay 
(Luo, Batalao et al. 1997), Split-TEV (Wehr, Laage et al. 2006), split-intein (Kanno, 
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Ozawa et al. 2006) split-ubiquitin (Stagljar, Korostensky et al. 1998) and proximity 
based assays e.g. mammalian protein-protein interaction trap assay (MAPPIT) and its 
modifications (Lemmens, Lievens et al. 2008) and the full length TEV based Tango 
assay (Barnea, Strapps et al. 2008). The mentioned techniques allow measurement of 
various protein-protein interactions including inducible, transient and modification 
dependent (Wehr, Reinecke et al. 2008). Additionally, any other events affecting the 
proximity of cellular components can be measured with these approaches e.g. 
proteolytic cleavage, protein degradation, translocation or specific subcellular 
localizations.  
A set of desired assays is assembled and encoded by coupling to the unique EXT 
reporters. Thereafter all the variety of assays can be performed in one large scale 
measurement by single microarray hybridizations.  
The capacity to accommodate large assay numbers and the unique versatility of the 
EXTassay approach makes it a potentially suitable tool for high throughput analysis 
of cellular signaling that involves very different types of cellular events.  
The main bottleneck on the way to comprehensive analysis of signaling networks with 
EXTassays is the generation and integration of new genetically encoded assays. Each 
assay is introduced to the cells in the form of one or several DNA constructs. Some 
assays are contained in a single DNA construct carrying e.g. a cis-regulatory element 
and a unique EXT reporter sequence. Such constructs can be easily generated and 
applied on a large scale. However, sequence verification is required to validate the 
appropriate coupling of the EXT. In the future, in situ oligonucleotide synthesis could 
be used to generate high numbers of cis-elements readily linked to a unique EXT 
sequence on one DNA stretch. 
Other assays involve expression of modified proteins and are encoded by more than 
one plasmid. Within the proof of principle experiment, we have performed the 
measurement of four such assays with the help of the split-TEV system. For each 
assay, a separate transfection was performed using two constructs encoding respective 
interaction partner proteins cotransfected with an appropriate unique EXT reporter 
plasmid. The separate transfection in this case is unavoidable to ensure unambiguous 
coupling to a specific EXT. Cells carrying different assays were combined after 
transfection and later assayed simultaneously. However, multiple transfections are 
inconvenient and time consuming. An ideal assay should require only one 
transfection. As a possible solution all the assay components could be cloned into one 
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DNA construct with a defined reporter EXT using. Using viral DNA transfer the 
constructs could be delivered to the cells in the amount adjusted such that every cell 
would receive maximally one construct. 
An easier solution towards multiplexed EXTassays could be performed by using the 
newly developed transfected cell arrays (Bailey, Wu et al. 2002). To apply this 
technique, appropriate combinations of plasmid DNA are spotted on the glass surface 
and overlaid with transfection reagents. The cells plated on top of such a surface 
receive defined combinations of plasmids different from spot to spot.    
Every assay to be integrated into the multiplexed measurement has to be functionally 
verified with respect to its performance. This requirement is the main difficulty that 
delays the development of the comprehensive EXTassay setup. However, once 
established the assay can be easily applied to very different studies to elucidate 
signaling mechanisms under different cellular context. Moreover, new assays can be 
incorporated at any time to improve the scope of the analysis.   
There are numerous potential applications of the EXTassay. It can be easily applied in 
the near future to quantitative profiling of the transcription factor activities for 
comprehensive analysis of the known and characterized transcription factors, the 
number of which in human genome is below 2000 (Papin, Hunter et al. 2005). If 
preferred, cis-element activity analysis can be combined with the standard gene 
expression microarray measurement to study the mechanisms of transcription 
regulation. Moreover, the EXT oligonucleotide library may be used as an improved 
barcoding strategy for the cellular survival assays (Silva, Marran et al. 2008). Even 
more importantly, one could apply the EXTassay to high throughput screening of 
small molecules. We hope that this assay will be useful for monitoring drug effects in 
living cells for example to identify the mechanisms of action for established drugs or 








ErbB signaling measurement with EXTassays 
In a biologically relevant proof of principle study, we were able to quantitatively 
measure the Nrg1 mediated activation of ErbB receptor tyrosine kinases with multiple 
diverse assays in one measurement. Our measurements of protein-protein interactions 
associated with the stimulated ErbB receptor complexes revealed several observations 
that are consistent with already published data. For example, we have detected ligand 
independent homodimerization of the ErbB2 protein accompanied by changes in the 
activity of several cis-regulatory elements. This is in good agreement with the ability 
of ErbB2 to induce transformation in cell culture by eliciting ligand independent 
signaling (Di Fiore, Pierce et al. 1987). The highest activation levels of both, protein 
interaction assays and cis-regulatory elements was exhibited by the ErbB2/ErbB3 
heterodimer expressing cells suggesting that this receptor combination demonstrates 
enhanced signaling properties, consistent with the literature (Alimandi, Romano et al. 
1995).    
ErbB proteins are the most extensively studied group of receptor tyrosine kinases. 
First order signaling complexes of each ErbB receptor were previously characterized 
with biochemical in vitro approaches (Schulze, Deng et al. 2005). These techniques, 
however, do not provide any direct information about the downstream signaling in a 
particular cellular context. By using EXTassays, we were for the first time able to link 
the activation of distinct ErbB receptor complexes to activation of certain cis-
regulatory elements in PC-12 cells by a simple and parallel measurement. Among the 
interesting observations is the reduction in p53 and AP-1 cis-regulatory element 
activities in response to ErbB2 overexpression. We have also been able to measure 
differential downstream signaling induced by distinct ErbB receptor complexes. For 
example, the AP-1 cis-regulatory element was differentially regulated by distinct 
ErbB receptor complexes. In the case of ErbB2 overexpression the AP-1 activity was 
suppressed relative to the control condition, while ErbB2/4 and ErbB2/3 receptor 
complexes have induces its activation. The cis-elements CRE and NFkB were shown 
to be exclusively activated by ErbB2/3 but not by ErbB2/4. 
The two cis-regulatory elements that exhibited the most prominent activation are SRE 
and AP-1, which are classical elements involved in growth factor signaling. SRE was 
primarily identified as the part of the c-fos promoter that mediated its response to the 
serum and is bound by the serum response factor (SRF) (Treisman 1986) AP-1 is an 
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element recognized by the protooncogenic transcription factors of the c-Jun family in 
the form of homodimers or heterodimers with the c-Fos and ATF proteins. Two major 
pathways triggered by the Nrg1 dependent ErbB receptor activation are mitogen 
activated protein kinase (MAPK) pathway and phosphatidylinositol 3-kinase (PI3K) 
pathway (Mei and Xiong 2008). In order to analyse the mechanism of cis-element 
activation in more detail, further experiments are definitely required. One could use 
pathway specific small molecule inhibitors or RNAi targeted against different 
components of the MAPK or PI3K pathways to determine which of these might 
participate in the induction of certain cis-regulatory elements. For large scale profiling 
of cis-element activation patterns in response to Nrg1, it might be useful to generate 
cell lines stably transfected with different receptor combinations. This would allow 
more reliable measurement free from the possible bias introduced by the transient 























In the present work, we have established an assay for the simultaneous and 
quantitative monitoring of several distinct cellular assays which we termed EXTassay. 
An “oligonucleotide” EXT-based reporter system was created that allows upscaling of 
the assay principally to high throughput levels. Therefore, we have developed a 
particular custom microarray design and optimized protocols for target preparation 
and hybridization. This allows a robust and specific identification of unique 
oligonucleotide reporters by microarray hybridization. The performance of the system 
was validated by numerous hybridization controls and a model experiment with 
synthetic transcription factor. 
Moreover, we successfully performed a proof of principle experiment using signaling 
proteins of the ErbB receptor tyrosine kinase family to assess their immediate and 
downstream signaling in PC-12 cells. The experiment demonstrated that the 
EXTassay approach can be used for monitoring differential signaling events at 
various levels of signal transduction networks. Ligand induced protein-protein 
interactions of the ErbB receptors at the plasma membrane were measured along with 
multiple DNA-regulatory elements at the transcriptional level. The obtained data were 
in the line with the current concepts of the ErbB biology suggesting the validity of the 
EXTassay based measurements. In addition, these experiments provided for the first 
time comprehensive and quantitative data of ErbB receptor signaling at the level of 
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